EurekaMag PDF full texts Chapter 30,812

Zou, L.; Mendez, F.; Martin-Orozco, N.; Peterson, E.J. 2008: Defective positive selection results in T cell lymphopenia and increased autoimmune diabetes in ADAP-deficient BDC2.5-C57BL/6 mice. European Journal of Immunology 38(4): 986-994

Gray, J.D.; Basin, K.; Horwitz, D.A. 1990: Defective post thymic maturation of cd4 positive t lymphocytes in patients with sle. Arthritis and Rheumatism 33(9 Suppl): S128

Mondino, A.; Giordano, S.; Comoglio, P.M. 1992: Defective post translational processing activates the tyrosine kinase encoded by the met hgf receptor proto oncogene. Journal of Cellular Biochemistry Suppl (16 Part B): 188

Tsukamoto, H.; Volanakis, J.E. 1995: Defective posttranslational processing of the product of an alternatively spliced human C2 mRNA. FASEB Journal 9(3): A517

Reddigari, S.R.; Kaplan, A.P. 1989: Defective prekallikrein protein in kininogen deficient plasma. Clinical Research 37(2): 549A

Masilamani, S.; Baylis, C. 1993: Defective pressure natriuresis in the ageing kidney. Journal of the American Society of Nephrology 4(3): 516

Loertscher, R.; Morelon, E.; Dodelet, V.; Baev, N.; Cashman, N.R. 1993: Defective prion protein expression in the lymphoblastoid B cell line Daudi. Tissue Antigens 42(4): 310

Donckier, V.; Abramowicz, D.; Durez, P.; Gérard, C.; Velu, T.; Goldman, M. 1994: Defective production of IFN-gamma in neonatally tolerant mice: involvement of IL-10. Transplantation Proceedings 26(1): 237

Vesterhus, P.; Abrahamsen, T.; Bjerknes, R.; Holland, S.M. 1997: Defective production of interferon gamma and interleukin 12 in a boy with disseminated Mycobacterium avium infection. Hormone Research 48(Suppl 2): 195

Tomita Yamaguchi, M.; Johnson, G.S.; Fairchild, R.C.; Santoro, T.J. 1990: Defective production of interleukin 2 is mediated at the level of gene transcription in b220 positive t cells from mrl lpr lpr mice. Arthritis and Rheumatism 33(9 Suppl): S128

Verfaillie, C.M.; Zhao, R.C.H.; Weber, E.; Bhatia, R. 1997: Defective progenitor/stroma interactions in the pathogenesis of chronic myeloid leukemia. Experimental Hematology 25(8): 874

Chikanza, I.C.; Petrou, P.; Kingsley, G.; Chrousos, G.; Panayi, G.S. 1992: Defective prolactin and cortisol response to surgery in rheumatoid arthritis. Arthritis and Rheumatism 35(9 Suppl): S197

Colmegna, Iés.; Diaz-Borjon, A.; Fujii, H.; Schaefer, L.; Goronzy, Jörg.J.; Weyand, C.M. 2008: Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis and Rheumatism 58(4): 990-1000

Esquivel, F.; Carrion, F.; Albillos, A.; Prieto, A.; Moragues, B.; Martinez, B.; Alvarez Mon, M. 1996: Defective proliferative response in peripheral blood mononuclear cells from chronic hepatitis C patients after surface and intracytoplasmatic mitogenic signals. European Journal of Clinical Investigation 26(Suppl 1): A16

Martinez Martin, B.; Carballido, J.; Perez Blas, M.; Alvarez Mon, M. 1996: Defective proliferative response to transmembrane stimuli in T lymphocytes from prostate cancer patients. European Journal of Clinical Investigation 26(Suppl 1): A18

Thomas, P.J.; Qu, B.H.; Pedersen, P.L. 1995: Defective protein folding as a basis of human disease. Trends in Biochemical Sciences 20(11): 456-459

Govoni, S.; Racchi, M.; Bergamaschi, S.; Trabucchi, M.; Battaini, F.; Bianchetti, A.; Binetti, G. 1996: Defective protein kinase C alpha leads to impaired secretion of soluble beta-amyloid precursor protein from Alzheimer's disease fibroblasts. Annals of the new York Academy of Sciences 777: 332-337

Miller, R.; Patel, H.; Shi, J. 1992: Defective protein kinase function in t cells from old mice. FASEB Journal 6(5): A1781

Naef, R.; Lescher, B.; Suter, U. 1996: Defective protein transport is the probable cause of the peripheral neuropathy in the trembler mouse. Experientia 52(ABSTR ): A40

Cayota, A.; Vuillier, F.; Scott Algara, D.; Siciliano, J.; Dighiero, G. 1993: Defective protein tyrosine phosphorylation and overexpression of p59-fyn, are associated to dysfunction of CD4 T cells from HIV-1 infected patients. IXTH INTERNATIONAL CONFERENCE ON AIDS and THE IVTH STD WORLD CONGRESS Author IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 222

Muegge, K.; Candeias, S.; Peschon, J.; Durum, S.K. 1997: Defective rearrangement of TCRgamma gene in IL-7Ralpha deficient mice. Cytokine 9(11): 939

Stockert, R.J.; Tao, L.; Spray, D.C.; Potvin, B.; Stanley, P.; Wolkoff, A.W. 1994: Defective receptor-mediated endocytosis in a mutant HuH-7 cell line is associated with absence of state 2 receptors. Hepatology 20(4 Part 2): 225A

Lasarte, J.J.; Bruna Romero, O.; Ruiz, J.; Quian, C.; Borras, F.; Prieto, J. 1998: Defective recombinant adenoviruses as a tool to induce anti-HCV immune responses. Biotecnologia Aplicada 15(3): 195

Heidmann, T.; Nicolas, J F. 1996: Defective recombinant retrovirus. Official Gazette of the United States Patent and Trademark Office Patents 1193(2): 1241

Nagafuchi, H.; Suzuki, N.; Sakane, T. 1998: Defective recombination-activating gene expression may contribute development of autoantibodies in patients with systemic lupus erythematosus. Arthritis and Rheumatism 41(9 Suppl): S71

Vassanelli, C.; Menegatti, G.; Molinari, J.; Zanotto, G.; Zardini, P. 1994: Defective regional endothelium-dependent and endothelium-independent coronary vasodilation in patients with angina pectoris and angiographically normal coronary arteries. European Heart Journal 15(ABSTR Suppl ): 424

Alleva, D.G.; Callaruso, T.; Howard, B.; Rothstien, T.; Kaser, S.B.; Beller, D.I. 1997: Defective regulation of B cells by macrophages from MRL/++, NZB/W F1, and BxSB lupus-prone mice. Journal of Leukocyte Biology (Suppl ): 8

Ravid, T.; Avner, R.; Polak Charcon, S.; Roitelman, J. 1997: Defective regulation of HMG-CoA reductase degradation in the lovastatin-resistant L-90 cells. FASEB Journal 11(9): A1274

Balachov, K.E.; Smith, D.R.; Khoury, S.J.; Hafler, D.A.; Weiner, H.L. 1995: Defective regulation of T-cell receptor-mediated IFN-gamma production by TH2-type cytokines in multiple sclerosis. Neurology 45(4 Suppl 4): A384

Bambrick, L.L.; Yarowsky, P.J.; Krueger, B.K. 1995: Defective regulation of astrocyte proliferation by glutamate in mouse trisomy 16. Society for Neuroscience Abstracts 21(1-3): 564

Davies, H.; Bagg, J.; Goodchild, M.C.; McPherson, M.A. 1991: Defective regulation of electrolyte and protein secretion in submandibular saliva of cystic fibrosis patients. Acta Paediatrica Scandinavica 80(11): 1094-1095

Bradbury, N.A.; Kirk, K.L.; Bridges, R.J. 1991: Defective regulation of endocytosis in cystic fibrosis cells is corrected in cells transduced with the normal cf gene. FASEB Journal 5(6): A1760

Flatt, P.R. 1990: Defective regulation of insulin secretion in diabetes and insulinoma. Biochemical Society Transactions 18(1): 124-127

Walter, M.; Reinecke, H.; Gerdes, U.; Nofer, J.R.; Seedorf, U.; Assmann, G. 1996: Defective regulation of phosphatidylcholine-specific phospholipases C and D in Tangier fibroblasts. Circulation 94(8): I152

Liechty, K.W.; Schibler, K.R.; Ohls, R.K.; Christensen, R.D. 1992: Defective regulation of transcripts for granulocytopoietic cytokines in newborn mice inoculated with escherichia coli. Clinical Research 40(1): 10A

Masuda, A.; Kondoh, F.; Fukami, H.; Tatematsu, M.; Okayama, H. 1992: Defective regulation of tropomyosin expression in transformation-resistant NRK cell mutants. Cell Structure and Function 17(6): 503

Welch, W.J.; Wilcox, C.S. 1993: Defective regulation of tubuloglomerular feedback by nitric oxide in Dahl-Rapp rats. Journal of the American Society of Nephrology 4(3): 526

Laffi G.; Gresele P.; Marra F.; Palermo A.; De Feo M.L.; Selli L.; Vezza R.; Gentilini P. 1990: Defective release and reduced total content of alpha and delta platelet plt granules in cirrhotic patients c is associated with in vivo platelet activation. Fibrinolysis 4(Suppl 1): 14

Arnold, J.; Sangwaiya, A.; Bhatkal, B.; Arnold, A. 2008: Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis. Medical Hypotheses 70(6): 1197-1200

Fais S.; Capobianchi M.R.; Di Marco P.; Pallone F.; Dianzani F.; Torsoli A. 1990: Defective release of interferon alpha by intestinal mucosal macrophages in crohns disease. Gastroenterology 98(5 Part 2): A448

Dellinger, M.; Hunter, R.; Bernas, M.; Gale, N.; Yancopoulos, G.; Erickson, R.; Witte, M. 2008: Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Developmental Biology 319(2): 309-320

Aiello, S.; Noris, M.; Corna, D.; Benigni, A.; Zoja, C.; Todeschini, M.; Remuzzi, G. 1994: Defective renal synthesis of nitric oxide in rats with reduced renal mass. Journal of the American Society of Nephrology 5(3): 936

Mcgowan, K.A.; Thuy, L.P.; Hankhammer, M.; Nyhan, W.L.; Barshop, B.A.; Naviaux, R.K.; Haas, R. 1998: Defective renal transport of biotin in a girl with Leigh syndrome. Journal of Investigative Medicine 46(1): 85A

Tsuchida, S.; Hiraoka, M.; Hori, C.; Suzuki, T.; Gejyo, F.; Ichikawa, I. 1996: Defective renin-angiotensin system in a subset of type 4 RTA with prominent medial hypertrophy of renal vasculature and interstitial changes in infancy. Journal of the American Society of Nephrology 7(9): 1344

Lambert, M.W.; Kumaresan, K.R. 1995: Defective repair of DNA interstrand cross-links in Fanconi anemia complementation group A. Journal of Cellular Biochemistry Suppl 1995(21A): 288

Mullenders, L.H.F.; Balajee, A.S.; Van Hoffen, A.; Van Zeeland, A.A. 1995: Defective repair of UV-induced damage in transcriptionally active genes in Cockaynes syndrome cells A consequence of the lack of recovery of UV-inhibited RNA synthesis?. Journal of Cellular Biochemistry Suppl 1995(21A): 316

Cooper, P.K.; Leadon, S.A. 1994: Defective repair of ionizing radiation damage in Cockayne's syndrome and xeroderma pigmentosum group G. Annals of the new York Academy of Sciences 726: 330-332

Schories, M.; Peters, T.; Rasenack, J. 1998: Defective replication and expression of HBV mutants from a patient without immunological markers. Hepatology 28(4 Part 2): 718A

Voeller, K.K.S.; Edge, P.; Heilman, K.M. 1994: Defective response inhibition in ADHD. Biological Psychiatry 35(9): 724

Voeller, K.K.S.; Alexander, A.; Heilman, K.M. 1990: Defective response inhibition in attention deficit hyperactivity disorder. Neurology 40(4 Suppl 1): 410

Takamatsu, J.; Ito, M.; Yamano, Y.; Fukao, T.; Sakane, S.; Ohsawa, N. 1996: Defective response of body height to growth hormone treatment in resistance to thyroid hormone with short stature. Endocrine Journal 43 Suppl: S131-S133

Ko, F.Y.; Chen, W.P.; Lin, C.Y. 1992: Defective response of plasma growth hormone to growth hormone releasing factor in growth hormone deficient children. Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 33(4): 243-250

Elkind, M.M.; Utsumi, H. 1992: Defective response of radiation-sensitive mutants to anisotonic shock. Bjr Suppl 24: 39-42

Osei, K. 1989: Defective resting and postprandial energy expenditure in nondiabetic young first degree relatives of niddm patients. Clinical Research 37(2): 457A

Cohen, L.E.; Zanger, K.; Brue, T.; Wondisford, F.E.; Radovick, S. 1999: Defective retinoic acid regulation of the Pit-1 gene enhancer: a novel mechanism of combined pituitary hormone deficiency. Molecular Endocrinology 13(3): 476-484

Remaley, A.T.; Hoeg, J.M.; Brewer, H.B. 1996: Defective reverse cholesterol transport in Tangier disease skin fibroblasts. Clinical Chemistry 42(6 Part 2): S291

Schaffer, S.W.; Harada, H. 1989: Defective sarcolemmal calcium pump in taurine deficient rats. FASEB Journal 3(4): A1060

Martin, T.M.; Wiens, G.D.; Kowalcyzk, C.; Rittenberg, M.B. 1996: Defective secretion of VH CDR2 mutant antibodies is characterized by increased association of the mutant heavy chains with molecular chaperones and is not a property of the light chain. Immunotechnology 2(4): 278

Martin, T.M.; Chen, Q.; Stevens, S.; Rittenberg, M.B. 1994: Defective secretion of an immunoglobulin caused by mutations in the heavy chain CDR2. Journal of Cellular Biochemistry Suppl 1994(18D): 208

Moore, R.; Miller, I. 1990: Defective secretion of mucilage is the cellular basis for agravitropism in primary roots of zea mays cultivar ageotropic. Plant Physiology 93(1 Suppl): 40

Ween, J.E.; Alexander, M.P.; Verfaellie, M. 1994: Defective semantic processes impair verbal learning. Neurology 44(4 Suppl 2): A382

Wakita, T.; Kakumu, K.; Yoshioka, K.; Shinagawa, T.; Ishiwaka, T.; Ito, Y.; Takayanagi, M. 1990: Defective short core variants in chronic hbv carriers. Hepatology 12(4 Part 2): 886

Corrigall, V.M.; Verwilghen, J.; Panayi, G.S. 1994: Defective signalling in rheumatoid arthritis T cells. FASEB Journal 8(4-5): A760

Schaffer, S.W.; Duan, J.; Schaffer, H.K.; Wilson, G. 1992: Defective sodium calcium exchange in diabetic cardiomyopathy. FASEB Journal 6(4): A1594

Anner, B.M.; Imesch, E.; Moosmayer, M. 1990: Defective sodium transport of ouabain resistant renal sodium potassium atpase. Experientia 46(ABSTR): A48

Anner, B.M.; Imesch, E.; Moosmayer, M. 1990: Defective sodium transport of purified ouabain resistant sodium potassium atpase. Journal of General Physiology 96(6): 94A

Tranel, D.; Damasio, A.R. 1990: Defective somatic state activation following ventromedial frontal damage in humans. Society for Neuroscience Abstracts 16(1): 27

Jockusch, H.; Laage, S.; Kaupmann, K.; Heimann, P. 1991: Defective sperm assembly in a neurological mutant of the mouse wobbler. Baccetti, B (Ed ) Serono Symposia Publications From Raven Press, Vol 75 Comparative Spermatology 20 Years After; Papers Presented at The 6th International Congress Of Spermatology, Siena, Italy, August 30-September 5, 1990 Xxxvi+1112p Raven Press: New York, New York, Usa Illus 861-864

Schmitz, G.; Klima, H.; Aslanidis, C.; Ullrich, K.; Fehringer, P.; Lackner, K.J. 1993: Defective splicing of the lysosomal acid lipase-mRNA in a patient with cholesteryl ester storage disease. Circulation 88(4 Part 2): I423

Finkel, M.S.; Srivastava, R.; Salama, G. 1992: Defective sr calcium release from bio 146 cardiomyopathic syrian hamster. Clinical Research 40(2): 146A

Magilavy, D.B. 1989: Defective stimulation of cd 8 positive lymphocytes by hepatic antigen presenting cells of mrl lpr mice. Arthritis and Rheumatism 32(4 Suppl): S53

Goldhill, J.; Zhao, L.; Xu, Y.L.; Donovan, V.; Burakoff, R. 1993: Defective stimulation of cyclic adenosine monophosphate by prostaglandin E2 in colonic epithelial cells during experimental colitis. Gastroenterology 104(4 Suppl): A708

Smith, M.S.R.hman; Patel, Y.; Flynn, G.; Savidge, G.F. 1998: Defective stimulus-response coupling in platelets from a patient suffering from a chronic bleeding disorder. Blood 92(10 Suppl 1 Part 1-2): 28A-29A

Superti Furga, A.; Hastbacka, J.; Cohn, D.H.; Wilcox, W.; Van Der Harten, H.J.; Rimoin, D.L.; Lander, E.S.; Steinmann, R.; Gitzelmann, R. 1995: Defective sulfation of proteoglycans in achondrogenesis type IB is caused by mutations in the DTDST gene The disorder is allelic to diastrophic dysplasia. American Journal of Human Genetics 57(4 Suppl): A48

Malmstrom, R.; Packard, C.J.; Caslake, M.; Bedford, D.; Stewart, P.; Shepherd, J.; Taskinen, M.R. 1996: Defective suppression of VLDL1 APO B production by insulin is an inherent feature of dyslipidemia in NIDDM. Diabetologia 39(Suppl 1): A65

Levin, B.E. 1995: Defective sympathetic activation and insulin release during PVN infusions of norepinephrine in obesity-prone rats. Society for Neuroscience Abstracts 21(1-3): 1461

Coppola, D.; Putong, P.B.; Finkelstein, S.; Cooper, H. 1995: Defective synthesis of beta-human chorionic gonadotropin in placenta percreta. Modern Pathology 8(1): 87A

Koerner, C.; Lehle, L.; Figura, K.V. 1995: Defective synthesis of lipid linked oligosaccharides in carbohydrate deficient glycoprotein syndrome type 1. Biological Chemistry Hoppe-Seyler 376(SPEC Suppl ): S117

Prosper, F.; Paramo, J.A.; Rifon, J.; Cuesta, B.; Hermida, J.; Rocha, E. 1994: Defective synthesis of vitamin K dependent factors induced by rhGM-CSF treatment. British Journal of Haematology 87(Suppl 1): 185

Hough, M.R.; Kay, R.; Humphries, R.K. 1992: Defective t cell development resulting from deregulated expression of m1 69 j11d heat stable antigen in transgenic mice. Experimental Hematology (Charlottesville) 20(6): 817

Giorgi, J.V.; Chou C C.; Gudeman, V.; O'rourke S.; Isacescu, V.; Detels, R.; Mistuyasu, R.T. 1992: Defective t cell responsiveness to recall antigens in hiv 1 infection is not due to selective loss of cd4 memory cells and is not abrogated by reverse transcriptase inhibitors in vivo or in vitro. Journal of Cellular Biochemistry Suppl (16 Part E): 62

Clerici, M.; Stocks, N.I.; Zajac, R.A.; Boswell, R.N.; Via, C.S.; Shearer, G.M. 1989: Defective t helper pathways in asymptomatic hiv positive individuals. FASEB Journal 3(4): A961

Takikawa, H.; Sano, N.; Minagawa, K.; Yamanaka, M. 1992: Defective taurocholate tca induced increase in biliary lipid excretion in hyperbilirubinemic mutant sprague dawley rats. Gastroenterology 102(4 Part 2): A897

Pathak, S.; Multani, A.S.; Sharma, H.W.; Narayanan, R.; Amoss, M.S. 1996: Defective telomerase activity is associated with spontaneous melanoma regression in Sinclair swine. Proceedings of the American Association for Cancer Research Annual Meeting 37: 600

Schallreuter, K.U.; Wood, J.M.; Ziegler, I.; Lemke, K.R.; Pittelkow, M.R.; Lindsey, N.J.; Gütlich, M. 1994: Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochimica et Biophysica Acta 1226(2): 181-192

Bradley, H.; Arthur, V.; Yanes, T.; Waring, R.; Emery, P. 1989: Defective thiol methyltransferase activity in rheumatoid arthritis an explanation for clinical features of the disease. British Journal of Rheumatology 28(Suppl 2): 51

Delovitch, T.L.; Zipris, D.; Rapoport, M.J.; Lazarus, A.H.; Hadzija, M. 1991: Defective thymic t cell activation in prediabetic nod mice detectable at the onset of insulitis a possible diagnostic indicator of predisposition to disease. Diabetes Research and Clinical Practice 14(Suppl 1): S24

Kapur, R.; Uffman, J.; Cooper, R.; Majumdar, M.; Williams, D.A. 1995: Defective thymocyte development in mice overexpressing the human membrane-associated form of stem cell factor. Blood 86(10 Suppl 1): 160A

Barton, K.; Muthusamy, N.; Fischer, C.; Leiden, J.M. 1996: Defective thymocyte proliferation, IL-2 production and T-dependent antibody production in transgenic mice expressing a dominant negative form of CREB. Blood 88(10 Suppl 1 Part 1-2): 464A

Medeiros-Neto, G.; Targovnik, H.M.; Vassart, G. 1993: Defective thyroglobulin synthesis and secretion causing goiter and hypothyroidism. Endocrine Reviews 14(2): 165-183

Kaysen, G.A.; Pan, X.M.; Couser, W.G.; Staprans, I. 1992: Defective tissue hydrolysis of chylomicrons in rats with Heymann nephritis persists in the absence of nephrotic serum. Journal of the American Society of Nephrology 3(3): 597

Sasseville, V.G.; Pauley, D.R.; Walsh, D.; Simon, M.A.; Sehgal, P.K.; Lackner, A.A. 1995: Defective trafficking of lentivirus-infected leukocytes to sites of granulomatous inflammation in chronic SIV infection in rhesus monkeys. Journal of Medical Primatology 24(4): 199

Schibler, K.R.; Liechty, K.W.; Christensen, R.D. 1991: Defective transcription of interleukin 6 in neonatal monocytes a possible mechanism underlying several antibacterial immune defects in neonates. Pediatric Research 29(4 Part 2): 277A

Villella, A.; Peyre, J.-B.; Aigaki, T.; Hall, J.C. 2006: Defective transfer of seminal-fluid materials during matings of semi-fertile fruitless mutants in Drosophila. Journal of Comparative Physiology. a Neuroethology Sensory Neural and Behavioral Physiology 192(12): 1253-1269

Lazarus, A.H.; Crow, A.R.; Freedman, J. 1998: Defective transmembrane signalling in lymphocytes from patients with autoimmune thrombocytopenic purpura. Experimental Hematology 26(8): 795

Sidhu, G.S.; Singh, A.K.; Sivaram, S.S.; Liu, K.; Vedbrat, S.S.; Kinchington, P.R.; Hay, J.; Friedman, R.M.; Maheshwari, R.K. 1993: Defective transport of HSV-1 and HIV glycoprotein in interferon-treated cells Role of intracellular pH. Journal of Interferon Research 13(Suppl 1): S202

Ali, A.F.M.; Yehia, A.; Hassan, M.; El Din, M.; El Shayeb, S.; Shams, E.; Azhar, A. 1998: Defective trophoblast interferons production as a cause of idiopathic recurrent spontaneous abortion. Fetal Diagnosis and Therapy 13(Suppl 1): 86-87

Pijnenborg, R.; Hanssens, M.; Spitz, B.; Van Assche, A. 1991: Defective trophoblast invasion in lupus anticoagulant patients. American Journal of Obstetrics and Gynecology 164(1 Part 2): 391

Mirshahi, S.; Lounes, K.C.; Lu, H.; Pujade Lauraine, E.; Mishal, Z.; Benard, J.; Bernadou, A.; Soria, C.; Soria, J. 1996: Defective tyrosine phosphorylation signalling induced by urokinase is responsible for defective urokinase-related migration in an ovarian cancer cell line. Fibrinolysis 10(Suppl 3): 114

Feldman, R.D.; Sinkey, C. 1989: Defective vascular beta adrenergic response in elderly subjects is corrected by a low sodium diet. Circulation 80(4 Suppl 2): II448

Salmasi A M.; Belcaro, G.; Nicolaides, A.N. 1990: Defective venoarteriolar reflex as a possible cause for ankle edema following nifedipine therapy. Journal of the American College of Cardiology 15(2 Suppl A): 172A

Reichle, A.; Diddens, H.; Altmayr, F.; Rastetter, J.; Andreesen, R. 1993: Defective vincristine accumulation in B-cell CLL and ways of circumvention. Proceedings of the American Association for Cancer Research Annual Meeting 34: 318

Holland, J.J. 1990: Defective viral genomes. Fields, B N And D M Knipe (Ed ) Fields Virology, Second Edition, Vols 1 And 2 Xix+1267p (Vol 1); Xix+1069p (Vol 2)+++raven Press: New York, New York, Usa Illus Maps 151-166

Fisher, A.G.; Smith, M.H.; Moore, M.M.; Daniels, R. 1990: Defective viruses in aids. AIDS Research and Human Retroviruses 6(1): 56-57

Chou W G.; Kriajevskaia, M.; Zhu, W. 1992: Defective zinc utilization pathway decreases gene expression. Journal of Cellular Biochemistry Suppl (16 Part D): 119

Schwab, M.; Bloch, J.; Duplain, H.; Sartori, C.; Scherrer, U. 2008: Defecto de la homeostasis del oxido nitrico Mecanismo comun subyacente de la insulina-resistencia, la hiperactividad simpatica y la morbi-mortalidad cardiovascular. Medicina (Buenos Aires) 68(3): 243-250

Wilson, P.G. 1994: Defects in BIMC homologue urchin are suppressed by mutations in NCD, the functional KAR3 homologue in Drosophila. Molecular Biology of the Cell 5(Suppl ): 411A

D.C.teau, J.F.; Lowsky, R.; Ichinohasama, R.; Dong, W.F.; Xu, Y.; Minden, M.; Kadin, M.E. 1997: Defects in DNA mismatch repair system are implicated in human T-cell lymphomas. Laboratory Investigation 76(1): 123A

Sorbera, L.A.; Morad, M. 1993: Defects in G regulatory protein leads to up regulation of cardiac calcium currents. Biophysical Journal 64(2 Part 2): A204

Hicklin, D.J.; Kageshita, T.; Dellaratta, D.V.; Boccaletti, V.; Ferrone, S. 1996: Defects in HLA class I antigen presentation machinery in melanoma cells. Maio, M Biomedical and Health Research, Vol 12; Immunology of human melanoma: Tumor-host interaction and immunotherapy 95-111

Kuang, Y.; Harington, A.; Zheng, X.; Mayer, L. 1998: Defects in IL-10 mediated T cell dependent B cell differentiation in common variable immunodeficiency. FASEB Journal 12(5): A923

Mukherjee, R.; Hewett, K.W.; Spinale, F.G. 1995: Defects in L-type Ca-2+ channel function and phosphorylation occur with supraventricular tachycardia induced dilated cardiomyopathy. Circulation 92(8): I656-I657

Martin, M.G.; Turk, E.; Lostao, M.P.; Kerner, C.; Wright, E.M. 1996: Defects in Na+/glucose cotransporter trafficking and function cause glucose-galactose malabsorption. Nature Genetics 12(2): 216-220

Reuber, B.E.; Germain Lee, E.; Morrell, J.C.; Geisbrecht, B.; Collins, C.; Ameritunga, R.; Moser, H.W.; Valle, D.; Gould, S.J. 1997: Defects in PEX1, a peroxisome-associated ATPase that interacts with PEX5 and PEX6, disrupt peroxisomal matrix protein import and are the most common cause of the peroxisome biogenesis disorders. Molecular Biology of the Cell 8(Suppl ): 115A

Reuber, B.E.; Germain Lee, E.; Morrell, J.C.; Geisbrecht, B.; Collins, C.; Ameritunga, R.; Moser, H.W.; Valle, D.; Gould, S.J. 1997: Defects in PEX1, a peroxisome-associated ATPase that interacts with PEX6, are the most common cause of Zellweger syndrome, neonatal adrenoleukodystrophy and infantile Refsum disease. American Journal of Human Genetics 61(4 Suppl): A54

Blagosklonny, M.V.; El Deiry, W.S. 1996: Defects in Raf-1p21-WAF1/C-IP1Rbc-myc signaling in PMA-resistant cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 37: 426

Ausiello, C.; Sestili, P.; Locardi, C.; Logozzi, A.; Modica, A.; Modesti, A.; Musiani, P.; Parlanti, E.; Rizza, P. 1994: Defects in T cell functions in immunocompetent mice injected with HIV-infected U937 cells Role of HIV. AIDS Research and Human Retroviruses 10(Suppl 1): S89

Crowle, A.J.; Cohn, D.L.; Poche, P. 1989: Defects in aids patient serum and macrophages and in serum of non aids patients with mycobacterium avium infection which decrease macrophage resistance to mycobacterium avium. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 77

Villarreal, F.R.; Alfonso, E.C.; Albert, D.M.; Forster, R.K. 1993: Defects in an injection-molded intraocular lens. Journal of Cataract and Refractive Surgery 19(3): 417-419

Conroy, L.A.; Howlett, S.J.; Byth, K.; Holmes, N.; Alexander, D. 1996: Defects in apoptosis in the thymus of a CD45-/-transgenic mouse. Biochemical Society Transactions 24(4): 609S

Choy, J.S.; Desai, A.A.; Kron, S.J. 1998: Defects in bud morphogenesis and mitotic cyclin degradation in mutants lacking NBN1, a yeast homolog of the ING1 tumor suppressor gene. Molecular Biology of the Cell 9(Suppl ): 491A

Zheng, X.X.; Rahmani, N.; Mayer, L. 1998: Defects in cytokine secretion and B cell maturation in patients with common variable immunodeficiency. FASEB Journal 12(5): A923

Friend, S.H. 1997: Defects in damage response elements Their utility as targets for therapy. AAAS Annual Meeting and Science Innovation Exposition 163: A82

Ge, M.; Freed, J.H. 1998: Defects in detergent resistant domains containing membranes. Biophysical Journal 74(2 Part 2): A141

Kramer, M.H.H.; Mulder, L.; Baars, P.A.; Kerckhaert, J.A.; Van Lier, R.A.W. 1996: Defects in fas function in an adult patient with autoimmune lymphoproliferative syndrome. British Journal of Haematology 93(Suppl 2): 115

Zhang, C.L.; Messing, A.; Chiu, S.Y. 1998: Defects in fine motor skills in Kv11-null mice. Society for Neuroscience Abstracts 24(1-2): 828

Jiang, R.; Lan, Y.; Norton, C.; Gridley, T. 1998: Defects in gastrulation and mesoderm migration in mice lacking the Sna gene. Developmental Biology 198(1): 224

Vaisman, A.; Varcenhko, M.; Umar, A.; Kunkel, T.A.; Risinger, J.I.; Barrett, J.C.; Chaney, S.G. 1998: Defects in hMSH6, but not in hMSH3, correlate with increased resistance and enhanced replicative bypass of cisplatin, but not oxaliplatin, adducts. Proceedings of the American Association for Cancer Research Annual Meeting 39: 159

Lo, C.W.; Fletcher, W.H. 1996: Defects in heart morphogenesis and the misregulation of CX43 gap junctions. Cellular and Molecular Biology (Noisy-Le-Grand) 42(CONGRESS Suppl ): S101

Dominguez, C.; Tremml, G.; Rosti, V.; Cattoretti, G.; Bessler, M. 1998: Defects in hematopoiesis of PNH cells in mice mosaic for a non-functional PIGA gene. Blood 92(10 Suppl 1 Part 1-2): 471A

Bak, S.B.e K.; Berdanier, C.D. 1995: Defects in hepatic mitochondrial F1F0ATPase of BHE/cdb rats. FASEB Journal 9(4): A749

Steinberg, J.P.; Phair, J.P. 1989: Defects in host defenses in hiv infection and aids characteristics and pathogenesis. Leoung, G And J Mills (Ed ) Infectious Disease And Therapy, Vol 3 Opportunistic Infections in Patients With The Acquired Immunodeficiency Syndrome Xxi+445p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 57-70

Despot, J.E.; Eagleton, L.E. 1994: Defects in immunoglobulin G , IgG subclasses, and antibody production in non-HIV patients with pulmonary disease due to Mycobacterium-avium-intracellulare. Journal of Allergy and Clinical Immunology 93(1 Part 2): 170

Schneider, G.B.; Yamamoto, N.; Popoff, S.N. 1994: Defects in inflammation-primed macrophage activation in two osteopetrotic mutations. FASEB Journal 8(4-5): A213

Buffington, C.K.; Kitabchi, A.E.; Givens, J.R.; Inouye, H. 1991: Defects in insulin action and its metabolism in hyperandrogenic females with non insulin dependent diabetes. Clinical Research 39(2): 166A

Carvalheiro, M.; Faguiha, I.; Fagulha, A.; Gomes, L.; Paiva, S.; Marta, E.; Sobral, E.; Leitao, F.; Pinto, M.L.; Ruas, M.M.A.; Buchanan, T. 1996: Defects in insulin secretion and insulin action characterize gestational diabetes in late pregnancy. Diabetologia 39(Suppl 1): A18

Van Haeften, T.W. 1993: Defects in insulin secretion in NIDDM: B-cell glucose insensitivity or glucose toxicity?. Netherlands Journal of Medicine 42(1-2): 30-35

Kruszynska, Y.T.; Home, P.D.; Mcintyre, N. 1990: Defects in insulin secretion or insulin sensitivity as the cause of glucose intolerance in hepatic cirrhosis. Journal of Hepatology 11(Suppl 2): S36

Diamanti-Kandarakis, E.; Argyrakopoulou, G.; Economou, F.; Kandaraki, E.; Koutsilieris, M. 2008: Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (PCOS). Journal of Steroid Biochemistry and Molecular Biology 109(3-5): 242-246

Vaishnaw, A.K.; Drappa, J.; Ohsako, S.; Chu, J.L.; Elkon, K.B. 1997: Defects in lymphocyte apoptosis cause lupus-like disease. Arthritis and Rheumatism 40(9 Suppl): S116

Ohtsuka, K.; Gray, J.D.; Stimmler, M.M.; Horwitz, D.A. 1998: Defects in lymphocytes production of TGF-beta1 in SLE do not correlate with disease activity of severity. Arthritis and Rheumatism 41(9 Suppl): S70

Nagel, J.E.; Chopra, R.K.; Adler, W.H. 1990: Defects in lymphokine expression in aging humans. Journal of Cellular Biochemistry Suppl (14 Part B): 19

Doherty, T.M.; Sher, A. 1997: Defects in macrophage effector function inhibit immunopathology induced by Mycobacterium avium infection but fail to alter bacterial growth in vivo. Journal of Allergy and Clinical Immunology 99(1 Part 2): S254

Coker, M.L.; Zellner, J.L.; Crumbley, A.J.IIi; Ding, W.C.; Spinale, F.G. 1998: Defects in matrix metalloproteinase inhibitory stoichiometry in patients with non-ischemic or ischemic dilated cardiomyopathy. Circulation 98(17): I179-I180

Andreev, V.V.; Bykhovskaya, O.A.; Bogdanova, L.E.; Kossovoi, A.L. 1994: Defects in medical care rendered to the population and forensic medical assessment thereof. Sudebno-Meditsinskaya Ekspertiza 37(2): 5-9

Chisaka, O. 1995: Defects in mice with disrupted hox genes. Congenital Anomalies 35(3): 348

Krekeler,M.P.S.; Guggenheim,S. 2008: Defects in microstructure in palygorskite-sepiolite minerals a transmission electron microscopy study. Applied Clay Science: 1 2, 98-105

Pollitt, R.J. 1993: Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death. Padiatrie und Padologie 28(1): 13-17

King, M.P.; Koga, Y.; Davidson, M.; Schon, E.A. 1992: Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the t-RNA-Leu mutation associated with MELAS. American Journal of Human Genetics 51(4 Suppl): A171

Davidson, M.; Koga, Y.; Schon, E.A.; King, M.P. 1994: Defects in mitochondrial protein synthesis and respiratory chain activity segregation with the MELAS-3271 mutation. Neurology 44(4 Suppl 2): A336

Hoek, A.; Van Kasteren, Y.M.; De Haan Meulman, M.; Schoemaker, J.; Drexhage, H.A. 1992: Defects in monocyte polarization and dendritic cell clustering capability in patients with premature ovarian failure. EOS-Rivista di Immunologia ed Immunofarmacologia 12(2): 101

Yki Jarvinen, H. 1993: Defects in muscle glucose transport and glycogen synthesis in diabetic humans. Mornex, R, Jaffiol, C, Leclere, J International Congress Symposium and Seminar Series; Progress in endocrinology 818-820

Ramsey, K.M.; Cloyd, M.W.; Stanton, G.J. 1989: Defects in natural killer cytotoxicity and responses to interferons with human immunodeficiency virus 1 infections. Clinical Research 37(1): 18A

Masson, S.; Stead, R.; Perdue, M.H. 1990: Defects in nerves and neural regulation of ion transport during intestinal inflammation in the rat. Gastroenterology 98(5 Part 2): A662

Gutmann, D.H.; Geist, R.T.; Xu, H.M.; Kim, J.; Limb, A.; Hoang, K.; Saporito Irwin, S. 1998: Defects in neurofibromatosis 2 protein function can arise at multiple levels related to several different protein interactions. Proceedings of the American Association for Cancer Research Annual Meeting 39: 282

Lindberg, F.P.; Bullard, D.C.; Caver, T.E.; Gresham, H.D.; Beaudet, A.L.; Brown, E.J. 1996: Defects in neutrophil function and host defense in IAP-deficient mice. FASEB Journal 10(6): A1203

Frongillo, R.F. 1992: Defects in neutrophil granulocytes and staphylococcal infections. Giornale di Malattie Infettive e Parassitarie 44(1): 55-60

Adeni, S.; Fadavi, S.; Dziedzic, K.; Vidyasagar, D.; Punwani, I. 1989: Defects in primary dentition following neonatal intubation. Clinical Research 37(4): 961A

Ridgway, D.; Borzy, M.S. 1991: Defects in production of interleukin 1 il 1 and or granulocyte macrophage colony stimulating factor gm csf in children treated for acute lymphoblastic leukemia all. Pediatric Research 29(4 Part 2): 149A

Christiansen, E.; Tibell, A.; Rasmussen, K.; Tyden, G.; Madsbad, S.; Transplantation, T.D.nish Swedish Study Group, O.M.tabolic Effect, O.P.ncreas 1993: Defects in quantitative and qualitative beta-cell function following successful segmental pancreas transplantation. Transplantation Proceedings 25(1 BOOK 1-2): 1186-1189

Rachel, R.A.; Murdoch, J.N.; Beermann, F.; Copp, A.J.; Mason, C.A. 1998: Defects in retinal axon trajectory in the visual system of two midline mouse mutants. Society for Neuroscience Abstracts 24(1-2): 1285

Neĭmark, A.I.; Aliev, R.T.; Nozdrachev, N.A.; Kraĭnichenko, S.V.; El'chaninova, S.A.; Zolovkina, A.G.; Popovtseva, A.V.; Bespalova, O.V. 2008: Defects in spermatogenesis and their correction in patients with chronic abacterial prostatitis. Urologiia 2008(1): 44 46-44 50

Beeler, T.; Fu, D.; Monaghan, E.; Gable, K.; Dunn, T. 1996: Defects in sphingolipid synthesis render S cerevisiae cells sensitive to Ca-2+. FASEB Journal 10(6): A979

Roop, D. 1995: Defects in the barrier. Science 267(5197): 474-475

Seliger, B.; Hoehne, A.; Harders, C.; Lohmann, S.; Knuth, A.; Momburg, F.; Huber, C. 1996: Defects in the MHC class I antigen presentation machinery in human tumors and murine in vitro models of oncogenic transformation. Human Immunology 47(1-2): 95

Laville, M.; Andreeli, F.; Perche, S.; Vallier, P.; Riou, J.P.; Vidal, H. 1998: Defects in the acute regulation of gene expression by insulin in overweighted type-2 diabetic patients. International Journal of Obesity 22(Suppl 3): S62

Hampal, S.; Padgham, N.D.; Bunt, S. 1992: Defects in the assessment of TM perforations. Clinical Otolaryngology and Allied Sciences 17(5): 462

Matsuura, H.; Harvat, B.L.; Jetten, A.M. 1998: Defects in the control of growth-regulatory proteins and expression of differentiation-specific genes in human squamous cell carcinomas. Proceedings of the American Association for Cancer Research Annual Meeting 39: 443

Cohen, N.R.; Taylor, J.S.H.; Guillery, R.W.; Soriano, P.; Furley, A. 1997: Defects in the corticospinal decussation of L1-CAM mutant mice. Society for Neuroscience Abstracts 23(1-2): 1969

Splitt, M.P.; Burn, J.; Goodship, J. 1996: Defects in the determination of left-right asymmetry. Journal of Medical Genetics 33(6): 498-503

Soudais, C.; Lisowska Grospierre, B. 1993: Defects in the expression of the TCR leading to immunodeficiencies. M-S (Medecine Sciences) 9(6-7): 764-767

Chaturvedi, S.; Newman, S.L.; Frame, P. 1994: Defects in the function of macrophages from HIV positive individuals in host defense against Histoplasma capsulatum. Abstracts of the General Meeting of the American Society for Microbiology 94: 162

Paululat, A.; Ohlmeier, S.; Goubeaud, A.; Renkawitz Pohl, R. 1994: Defects in the fusion of myoblasts to myotubes in the Drosophila rolling stone mutant. Journal of Cellular Biochemistry Suppl 1994(18D): 481

Khillan, J.S.; Arita, M.; Zappola, D. 1994: Defects in the lens fiber cell differentiation in transgenic mice. IOVS Investigative Ophthalmology and Visual Science: 35(4)

Lowsky, R.; Ichinohasama, R.; Kadin, M.E.; Decoteau, J.F. 1997: Defects in the mismatch repair gene, hMSH2 are a feature of the human T-cell malignancy primary cutaneous CD30+ lymphoproliferative disorder. Blood 90(10 Suppl 1 Pt 1): 79A

Kronert, W.A.; Fieck, A.; O'donnel, P.T.; Vigoreaux, J.O.; Sparrow, J.C.; Bernstein, S.I. 1994: Defects in the myosin rod permit normal thick filament assembly but cause muscle degeneration. Journal of Cellular Biochemistry Suppl 1994(18D): 509

Zulkarneev, R.A.; Zulkarneev, R.R. 1994: Defects in the osseous base of the skeleton and possibilities of their correction by biologically justified methods. Kazanskii Meditsinskii Zhurnal 75(3): 226-229

Hooijkaas, H.; Van, D.M.rwe, J.P.; Drexhage, H.A. 1995: Defects in the polarization of granulocytes and monocytes as causes for immunodeficiency. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 386

Zhu, L.Min 1994: Defects in the precore region of the HBV genome in patients with chronic hepatitis B after interferon therapy. Hepatology 20(4 Part 2): 418A

Nowak Goettl, U.; Schneider, C.; Schwabe, D.; Schneppenheim, R. 1997: Defects in the protein C anticoagulant pathway and further risks of thrombophilia - first results of the German multicenter study on thromboembolism in childhood ALL. Blood 90(10 Suppl 1 Pt 1): 72A

Kadereit, S.; Xu, H.; Yang, Y.L.; Weissmann, C.; Fairchild, R.; Williams, B.R.G. 1997: Defects in the regulation of contact hypersensitivity in PKR deleted mice. Journal of Interferon and Cytokine Research 17(Suppl 2): S43

Tappia, P.S.; Pasricha, A.K.; Dhalla, N.S.; Panagia, V. 1998: Defects in the response of sarcolemmal PLC isoenzymes to phosphatidic acid in CHF. Journal of Molecular and Cellular Cardiology 30(7): A256

Yamamoto, S.; Sippel, K.C.; Berson, E.L.; Dryja, T.P. 1997: Defects in the rhodopsin kinase gene in patients with the Oguchi form of stationary night blindness. IOVS Investigative Ophthalmology and Visual Science 38(4 Part 1-2): S797

Mcgee, T.L.; Lin, D.; Berson, E.L.; Dryja, T.P. 1994: Defects in the rod cGMP-gated channel gene in patients with retinitis pigmentosa. IOVS Investigative Ophthalmology and Visual Science 35(4): 1716

Chazal, G.; Moreau, H.; Monti, G.; Cremer, H.; Rougon, G. 1996: Defects in the rostral migratory stream of NCAM/mCD24 double mutant mice. Society for Neuroscience Abstracts 22(1-3): 530

Alvarez Moya, C.; Gonzalez Avila, M.; Gonzalez Montes, R.M.ria 1993: Defects in the skeletal proteins of the erythrocyte are human skeleton. Ciencia (Mexico City) 44(3): 323-328

Rozing, J.; Coolen, C.; Tielen, F.J.; Weegenaar, J.; Schuurman, H.J.; Greiner, D.L.; Rossini, A.A. 1989: Defects in the thymic epithelial stroma of diabetes prone BB rats. Thymus 14(1-3): 125-135

D.Vijlder, J.J.M. 1993: Defects in thyroglobulin gene expression. Mornex, R, Jaffiol, C, Leclere, J International Congress Symposium and Seminar Series; Progress in endocrinology 321-325

D.V.jlder, J.J.M.; Vulsma, T. 1997: Defects in thyroid hormone biosynthesis. Hormone Research 48(Suppl 2): 4

Cooper, P.K.; Leadon, S.A. 1995: Defects in transcription-coupled repair of ionizing radiation-induced DNA damage in XP group G and Cockayne syndrome. Journal of Cellular Biochemistry Suppl 1995(21A): 310

Cooper, P.K.; Nouspikel, T.; Clarkson, S.G.; Leadon, S.A. 1998: Defects in transcription-coupled repair of oxidative base damage Mechanisms and consequences. Environmental and Molecular Mutagenesis 31(Suppl 29): 18

Tanaka, T.; Saiki, O.; Katada, Y.; Ochi, H.; Aitani, M.; Hashimoto, S.; Tawa, A.; Kikutani, H.; Suemura, M.; Kishimoto, T. 1994: Defects of CD40-mediated signalling in B-cells from patients with hyper IgM syndrome. Journal of Cellular Biochemistry Suppl 1994(18D): 379

Yamanaka, T.; Kinoshita, M.; Hatama, Y.; Nomoto, T.; Fujino, M.A. 1996: Defects of HBV DNA pre-S region in serum of anti-HBe phase asymptomatic HBV carrier and chronic hepatitis type B. Hepatology 24(4 Part 2): 600A

Cheknev, S.B. 1995: Defects of a fibronectin in a pathology of endogenous biological retranslation. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 474

Bohm, M.; Moll, M.; Paul, M.; Ganten, D.; Castellano, M.; Erdmann, E. 1994: Defects of adenylyl cyclase in transgenic rats with renin hypertension. Naunyn-Schmiedeberg's Archives of Pharmacology 349(Suppl): R49

Hojo, Y.; Ebata, H.; Ikeda, U.; Natsume, T.; Shimada, K. 1994: Defects of calcium-binding protein in male hypertensive subjects with genetic predisposition of stroke. American Journal of Hypertension 7(4 Part 2): 96A

Zandieh, T.; Marzban, S.; Tarabadi, F.; Ansari, H. 1990: Defects of cell mediated immunity in mustard gas injury after years. Scandinavian Journal of Immunology 32(4): 423

Jackson, S.; Turnbull, D.M. 1994: Defects of fatty acid oxidation. Darley-Usmar, V, Schapira, A H V Portland Press Research Monograph; Mitochondria: DNA, proteins and disease 201-220

Makino, N.; Nakanishi, H.; Matsui, H.; Yano, K.; Yanaga, T. 1990: Defects of heart membrane in diabetic cardiomyopathy. Japanese Circulation Journal 54(7): 718

Zarjevski, N.; Terrettaz, J.; Cusin, I.; Rohner Jeanrenaud, F.; Jeanrenaud, B. 1990: Defects of insulin responsive glucose transporter messenger rna in pre obese pups. Diabetologia 33(Suppl): A32

De Graaf, J.; Stalenhoef, A.F. 1998: Defects of lipoprotein metabolism in familial combined hyperlipidaemia. Current Opinion in Lipidology 9(3): 189-196

Zeviani, M.; Antozzi, C. 1992: Defects of mitochondrial DNA. Brain Pathology 2(2): 121-132

Ruitenbeek, W.; Huizing, M.; Depinto, V.; Thinnes, F.P.; Trijbels, J.M.F.; Wendel, U.; Sengers, R.C.A. 1995: Defects of mitochondrial membrane-bound transport proteins in human mitochondriopathies A biochemical approach. Palmieri, F , Papa, S , Saccone, C , Gadaleta, M N Progress in Cell Research; Thirty years of progress in mitochondrial bioenergetics and molecular biology 225-229

Miyabayashi, S.; Hanamizu, H.; Nakamura, R.; Endo, H.; Tada, K. 1992: Defects of mitochondrial respiratory enzymes in cloned cells from MELAS fibroblasts. Journal of Inherited Metabolic Disease 15(5): 797-802

Marth, T.; Neurath, M.; Cuccherini, B.; Schneider, T.; Holland, S.; Zeitz, M.; Strober, W. 1997: Defects of monocyte IL-12 production and humoral immunity in Whipples disease. Journal of Allergy and Clinical Immunology 99(1 Part 2): S26

Dominguez, J.; Bloom, R.; Rothrock, J. 1989: Defects of myo inositol transport in the diabetic rat proximal tubule. Kidney International 35(1): 426

Johnston, R.B. 1982: Defects of neutrophil function. New England Journal of Medicine 307(7): 434-436

Taylor, R.W.; Birch-Machin, M.A.; Lowerson, S.; Sherratt, H.S.; West, I.C.; Bartlett, K.; Turnbull, D.M. 1993: Defects of oxidative phosphorylation in man. Biochemical Society Transactions 21(3): 804-807

Mcglasson, D.L. 1992: Defects of plasma clotting factors. Harmening, D M (Ed ) Clinical Hematology And Fundamentals Of Hemostasis, Second Edition Xlviii+657p F A Davis Co : Philadelphia, Pennsylvania, Usa Illus Maps 462-485

Cannon, S.C.; Hayward, L.J. 1997: Defects of slow inactivation among Na+ channel mutations causing myotonia and periodic paralysis. Greger, R Author, Jentsch, T Journal Author Nova Acta Leopoldina; Ion channels and disease : 125-126

Pahwa, S.; Oyaizu, N.; Chirmule, N.; Gupta, A.; Slade, H.; Good, R.A.; Pahwa, R. 1989: Defects of t cell activation in scid after bmt. Pediatric Research 25(4 Part 2): 167A

Wahlsten, D.; Ozaki, H.S. 1994: Defects of the fetal forebrain in acallosal mice. Lassonde, M, Jeeves, M A Advances in Behavioral Biology; Callosal agenesis: A natural split brain 125-133, 1993

Yoo, S.J.; Lim, T.H.; Park, I.S.; Hong, C.Y.; Song, M.G.; Kim, S.H. 1991: Defects of the interventricular septum of the heart: en face MR imaging in the oblique coronal plane. Ajr. American Journal of Roentgenology 157(5): 943-946

Edwards, M.J.; Cawdell Smith, J.; Smith, M.S.R.; Upfold, J. 1990: Defects of the neural tube and head induced in early guinea pig embryos by hyperthermia. Teratology 42(6): 29A

Slater, C.R.; Fawcett, P.R.W.; Gardner Medwin, D.; Lyons, P.R.; Walls, T.J.; Wood, S.J.; Young, C. 1995: Defects of the neuromuscular junction associated with impaired neuromuscular transmission in limb-girdle myasthenias in man. Journal of Physiology (Cambridge) 489P: 150P-151P

Blanda, J.B. 1990: Defects of the pars interarticularis in athletes. Orthopaedic Transactions 14(3): 804-805

Vallejo, A.N.; Brandes, J.C.; Weyand, C.M.; Goronzy, J.J. 1998: Defects of transcriptional control of CD28 expression in patients with rheumatoid arthritis. Arthritis and Rheumatism 41(9 Suppl): S341

Eisner, R.L.; Martin, S.E.; Carey, D.; Schmarkey, L.S.; Worthy, M.; Chu, T.H.; Horowitz, S.F.; Patterson, R.E. 1993: Defects on SPECT perfusion images can occur due to abnormal segmental contraction despite normal myocardial blood flow. Journal of the American College of Cardiology 21(2 Suppl A): 376A

Kleditzsch, J.; Schulze, K.J. 1992: Defects resulting from chronic disuse or from application of physical aids. Pedotti, A, Ferrarin, M Medical and Health Research Program of the European Communities; Restoration of walking for paraplegics: Recent advancements and trends: 35-37

Boselli,M. 2008: Defence against Cydia in Emilia-Romagna. Informatore Agrario: 15, 33-35

Pollini,A. 2008: Defence against Cydia pomonella by attacking the first generation. Informatore Agrario Supplemento: 21,Supplemento N. 1, 5-6

Moretti,A. 2008: Defence against Fusarium disease can start with the seed. Informatore Agrario: 34, 47-49

Gamboa, G.J.; Wacker, T.L.; Duffy, K.G.; Dobson, S.W.; Fishwild, T.G. 1992: Defence against intraspecific usurpation by paper wasp cofoundresses. Canadian Journal of Zoology 70(12): 2369-2372

Gilbert, P. 1993: Defence and safety: their function in social behaviour and psychopathology. British Journal of Clinical Psychology 32(2): 131-153

Hendry, G.A.F. 1993: Defence chemistry Leaves. Hendry, G. A. F. , Grime, J. P. Methods In Comparative Plant Ecology: A Laboratory Manual. 113-115

Hendry, G.A.F. 1993: Defence chemistry Seeds. Hendry, G. A. F. , Grime, J. P. Methods In Comparative Plant Ecology: A Laboratory Manual. 180-181

ZhangTao; LiQunYing; ZhangChuanBo 2008: Defence fungi mechanism of insects and its research progress. Guizhou Agricultural Sciences: 69-72

Hart, C. 1992: Defence mechanisms against infection in pregnancy. Journal of Obstetrics and Gynaecology 12(Suppl 1): S14-S15

Varadi, G.Y.; Polos, E. 1992: Defence mechanisms against photooxidative damage in paraquat-atrazine co-resistant Conyza canadensis. Murata, N Research in photosynthesis, Vol IV: 495-499

Sgherri, C.L.M.; Quartacci, M.F.; Bochicchio, A.; Navari Izzo, F. 1994: Defence mechanisms against production of free radicals in cells of resurrection plants. Proceedings of the Royal Society of Edinburgh Section B (Biological Sciences) 102: 291-294

Abram, M.; Doric, M. 1995: Defence mechanisms involved in primary Listeriosis in mice. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 342

Diaz Otero, F.; Santiago Cruz, J.R.ul 1992: Defence mechanisms of the bovine mammary gland during the involution and lactation stages. Veterinaria - Mexico 23(4): 357-365

Creaser, E.H.; Britt, K.A.; Delbridge, T.; Broderick, K.; Rolfe, B.G. 1993: Defence proteins of clover. Fritig, B, Legrand, M Developments in Plant Pathology; Mechanisms of plant defense responses: 353

Shishkin, G.S.; Preobrazhenskaya, V.K.; Krasulina, G.P.; Bystrova, N.P.; Umantseva, N.D.; Gul'tyaeva, V.V. 1998: Defence reaction of the external respiration system to long-acting ecological factors. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1998(9): 45-48

Floerl,S.; Druebert,C.; Majcherczyk,A.; Karlovsky,P.; Kues,U.; Polle,A. 2008: Defence reactions in the apoplastic proteome of oilseed rape attenuate Verticillium longisporum growth but not disease symptoms. Bmc Plant Biology: 129, (18 Ember)

Baier, P. 1996: Defence reactions of Norway spruce to controlled attacks of Ips typographus in relation to tree parameters. Journal of Applied Entomology 120(10): 587-593

Malolepsza, U.; Urbanek, H. 1994: Defence reactions of strawberry plants after infection with Botrytis cinerea and salicylic acid treatment. Biologia Plantarum 36(Suppl ): S334

Haghighat, R. 1997: Defence strategies against stigmatisation of schizophrenia. European Psychiatry 12(Suppl 2): 180S

Distefano, G.; La Malfa, S.; Vitale, A.; Lorito, M.; Deng, Z.; Gentile, A. 2008: Defence-related gene expression in transgenic lemon plants producing an antimicrobial Trichoderma harzianum endochitinase during fungal infection. Transgenic Research 17(5): 873-879

Kowal, S.M. 1991: Defending food and drug criminal cases in a new era of criminal enforcement. Food Drug Cosmetic Law Journal 46(2): 273-310

Simonian, L. 1995: Defending the land of the jaguar A history of conservation in Mexico. Simonian, L Defending the land of the jaguar: A history of conservation in Mexico xv+326p

Bianco,M.; Re,M.I. 2008: Defending the sexual and reproductive health rights of women affected by HIV in Argentina. Exchange On Hiv Aids, Sexuality And Gender: 10-11

Harby, K. 1995: Fetal surgery: the challenge of operating before birth. Molecular Medicine Today 1(7): 310-313

Polle, A. 1997: Defense against photooxidative damage in plants. Scandalios, J G Cold Spring Harbor Monograph Series; Oxidative stress and the molecular biology of antioxidant defenses: 623-666

Wirth, G. 1997: Defense and illustration of prolapse treatment by the upper approach Regarding 165 Scalis interventions. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 26(Suppl 3): 139-143

Baeza-Squiban, A.; Boisvieux-Ulrich, E.; Delcher, L.; Marano, F. 1998: Defense and repair mechanisms in the airway epithelium exposed to oxidative stress: effects of analogues of retinoic acid. Toxicology Letters 96-97: 245-251

Ratey, J.J.; Grandin, T.; Miller, A.; Grandin, T. 1992: Defense behavior and coping in an autistic savant: the story of Temple Grandin, PhD. Psychiatry 55(4): 382-391

Deslippe, R.J.; Jelinski, L.; Eisner, T. 1996: Defense by use of a proteinaceous glue Woodlice vs ants. Zoology 99(3): 205-210, 1995-

Wingsle, G. 1990: Defense enzymes and autooxidants in air polluted scots pines. Physiologia Plantarum 79(2 Part 2): A122

Delacourt, C.; Harf, A.; Lafuma, C. 1993: Defense functions of alveolar macrophages in the course of growth. SERVICE DE MEDECINE NEONATALE DE PORT-ROYAL, CENTRE DE RECHERCHES DE BIOLOGIE DU DEVELOPPEMENT FOETAL ET NEONATAL DE L'HOPITAL PORT-ROYAL, SOCIETE FRANCAISE DE NEONATOLOGIE, Progress in Neonatology; Twenty-third national meeting on neonatology, Progres en Neonatologie; XXIIIes journees nationales de neonatologie: 93-102

Dixon, R.; Harrison, M.; Lawton, M.; Jenkins, S.; Lamb, C. 1989: Defense gene transcription factors. Journal of Cellular Biochemistry Suppl (13 Part D): 247

Garcia Olmedo, F.; Molina, A. 1994: Defense genes and proteins in barley. Biologia Plantarum 36(Suppl ): S1

Fineschi, F. 1994: Defense in depth against the hydrogen risk A European research program. Nuclear Safety 35(2): 235-245

Kayashima, S.; Shinomiya, N.; Wakiyama, H.; Okumura, A.; Rokutanda, M. 1995: Defense mechanism against listeria infection in SCID mice modified with G-CSF and anti-asialo GM1 antibody in vivo. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 353

Seelenfreund, D.; Castaneda, P.; Lobos, S.; Ortega, X.; Polanco, R.; Quiroz, M.; Perez, L.M. 1997: Defense mechanism of Citrus limon seedlings against fungal pathogens Signal transduction and PAL gene. FASEB Journal 11(9): A1104

Guinel, F.C.; Larue, T.A. 1989: Defense mechanism to iron toxicity in a single gene pea mutant. American Journal of Botany 76(6 Suppl): 66-67

Dmitriev, A.P.; Tverskoy, L.A.; Grodzinsky, D.M. 1989: Defense mechanisms in onion. Journal of Cellular Biochemistry Suppl (13 Part C): 65

Hell, D. 1991: Defense mechanisms in psychiatric institutions. Praxis der Psychotherapie und Psychosomatik 36(4): 189-194

Peters, A.; Ehlers, R.U. 1996: Defense mechanisms of Tipula oleracea against the insect-pathogenic antagonist complex Steinernema feltiae - Xenorhabdus bovienii. Laux, W, Communications from the Federal Biological Institute for Agriculture and Forestry Berlin-Dahlem, Mitteilungen aus der Biologischen Bundesanstalt fuer Land- und Forstwirtschaft Berlin-Dahlem: 439

Tripp, M.R.; Hackett, K. 1991: Defense mechanisms of geukensia demissa. Journal of Shellfish Research 10(1): 278-279

Furowicz, A.J. 1991: Defense mechanisms of the eyeball with special regard to the cornea. Medycyna Weterynaryjna 47(8): 360-363

Demeter, S.L.; Pipoly, D.J.; Koo, P.H. 1995: Defense mechanisms of the respiratory system. Cordasco, E M, Sr, Demeter, S L, Zenz, C Environmental respiratory diseases 39-83

Droy-Lefaix, M.T. 1989: Defense mechanisms of the stomach and Campylobacter pylori. Gastroenterologie Clinique et Biologique 13(1 Part 1): 13b-17b

Feucht, W. 1990: Defense mechanisms of woody plants involving natural substances. Bayerisches Landwirtschaftliches Jahrbuch 67(Special Issue 2): 49-56

Lingiardi, V.; Lonati, C.; Vanzulli, L.; Beretta, F.; Maffei, C. 1997: Defense mechanisms rating scale and personality disorders. European Psychiatry 12(Suppl 2): 142S

Douki, S. 1991: Defense of benzodiazepines is there a future for benzodiazepines in psychiatry. Encephale 17(2): 57-59

Shilkoff, W.; Kaji, D. 1998: Defense of cellular magnesium 1 in normals and in chronic renal failure. FASEB Journal 12(4): A426

Belaisch Allart, J.; Alnot, M.O.; Bernard, J.P.; Buhler, M.; Neiman, A.F. Beau; Laroussinie, M.P.; Fourrier, E.; De Plunkett, T.; Taurelle, R. 1993: Defense of intrauterine insemination. Contraception Fertilite Sexualite 21(6): 495-497

Delpeyroux, F. 1993: Defense of the organism against viral infections Viral immunology and interferon. Crainic, R , Nicolas, Journal -C Medical Biology Collection; Medical virology Collection Biologie Medicale; Virologie medicale : 109-135

Müller-Schwarze, D.; Thoss, V. 2008: Defense on the rocks: low monoterpenoid levels in plants on pillars without mammalian herbivores. Journal of Chemical Ecology 34(11): 1377-1381

Fritig, B.; Kauffmann, S.; Rouster, J.; Dumas, B.; Geoffroy, P.; Kopp, M.; Legrand, M. 1990: Defense proteins glycanhydrolases and oligosaccharide signals in plant virus interactions. Fraser, R S S (Ed ) Nato Asi (Advanced Science Institute) Series Series H Cell Biology, Vol 41 Recognition And Response in Plant-Virus Interactions; Workshop, Chichester, England, Uk, April 12-16, 1989 Ix+467p Springer-Verlag: Berlin, Germany; New York, New York, Usa Illus 375-394

Pandossio, J.E.; Brandao, M.L. 1997: Defense reaction in the inferior colliculus Induction by microinjections of glutamate and inhibition by muscimol and midazolam. Society for Neuroscience Abstracts 23(1-2): 1319

Arshavsky, Y.I.; Deliagina, T.G.; Okshtein, I.L.; Orlovsky, G.N.; Panchin, Y.V.; Popova, L.B. 1994: Defense reaction in the pond snail Planorbis corneus. I. Activity of the shell-moving and respiratory systems. Journal of Neurophysiology 71(3): 882-890

Arshavsky, Y.I.; Deliagina, T.G.; Okshtein, I.L.; Orlovsky, G.N.; Panchin, Y.V.; Popova, L.B. 1994: Defense reaction in the pond snail Planorbis corneus. II. Central pattern generator. Journal of Neurophysiology 71(3): 891-897

Arshavsky, Y.I.; Deliagina, T.G.; Okshtein, I.L.; Orlovsky, G.N.; Panchin, Y.V.; Popova, L.B. 1994: Defense reaction in the pond snail Planorbis corneus. III. Response to input from statocysts. Journal of Neurophysiology 71(3): 898-903

Prost, M. 1998: Defense reactions against parasitic invasions in fish. Medycyna Weterynaryjna 54(9): 579-582

Armero, J.; Cabello, F.; Cachinero, J.M.; Lopez Valbuena, R.; Jorrin, J.; Jimenez Diaz, R.M.; Tena, M. 1993: Defense reactions associated to host-nonspecific and host-specific interactions in the chickpea Fusarium oxysporum pathosystem. Fritig, B, Legrand, M Developments in Plant Pathology; Mechanisms of plant defense responses: 316-319

Mayoral, A.C.; Escande, A.; Daleo, G.R. 1997: Defense reactions in bean plants protected against Rhizoctonia solani by treatment with Rhizoctonia binucleate isolates. Phytopathology 87(6 Suppl): S63

Hahlbrock, K. 1996: Defense reactions of plants to pathogenic fungi. Experientia 52(ABSTR ): A19

Brey, P.T.; Ashida, M. 1991: Defense reactions of the silkworm larva which is abraded at its cuticle. Zoological Science 8(6): 1050

TianShiPing; Harman,G. 2008: Defense response induced by seed treatment with Trichoderma harzianum in maize Mo17. Acta Phytopathologica Sinica: 6, 626-634

Persiyanova,E.V.; Kiselev,K.V.; Bulgakov,V.P.; Timchenko,N.F.; Chernoded,G.K.; Zhuravlev,Yu.N. 2008: Defense response mechanisms of ginseng callus cultures induced by Yersinia pseudotuberculosis, a human pathogen. Russian Journal Of Plant Physiology: 6, 748-755

O'neill N.R. 1991: Defense responses and the role of medicarpin in resistance in alfalfa to colletotrichum trifolii. Phytopathology 81(10): 1198

Vahamiko, S.; Montesano, M.; Karls, M.; Sims, K.; Tas, E.; Palva, T.; Vidal, S.; Norman, C. 1998: Defense responses of plants to the non-specific bacterial pathogen Erwinia carotovora. Plant Biology (Rockville) : 147-148

Fernandez Pavia, S.; Liddell, C.M.; Biles, C.L. 1993: Defense responses of susceptible and resistant peppers to Phytophthora capsici. Phytopathology 83(12): 1334

Foldi, I. 1997: Defense strategies in scale insects Phylogenetic inference and evolutionary scenarios. Memoires du Museum National d'Histoire Naturelle 173: 203-230

Chakraborty, B.N.; Chakraborty, U.; Saha, A. 1995: Defense strategies of tea against fungal pathogens. Daniel, M, Purkayastha, R P Handbook of phytoalexin metabolism and action 485-501

Lucas, J.R.; Waser, P.M. 1989: Defense through exploitation a skinner box for tropical rain forests. Trends in Ecology and Evolution 4(3): 62-63

Heil, M.; Lion, U.; Boland, W. 2008: Defense-inducing volatiles: in search of the active motif. Journal of Chemical Ecology 34(5): 601-604

Lawrence, C.B.; Singh, N.P.; Tuzun, S. 1996: Defense-related gene expression during compatible and incompatible interactions of tomato with Alternaria solani. Phytopathology 86(11 Suppl): S106-S107

Steiner, M.G.; Babbs, C.F. 1990: Defenses limiting hydroxyl radical generation in postischemic kidney slices. Free Radical Biology and Medicine 9(Suppl 1): 21

Minns, C.K.; Meisner, J.D.; Moore, J.E.; Greig, L.A.; Randall, R.G. 1995: Defensible methods for pre- and post-development assessment of fish habitat in the Great Lakes I A prototype methodology for headlands and offshore structures. Canadian Manuscript Report of Fisheries and Aquatic Sciences 1995(2328): I-XIII, 1-65

Gottsch, J.D.; Li, Q.; Ashraf, M.F.; O'Brien, T.P.; Stark, W.J.; Liu, S.H. 1998: Defensin gene expression in the cornea. Current Eye Research 17(11): 1082-1086

Kaplan, S.S.; Heine, P.; Simmons, R.L. 1997: Defensin mediated paracrine impairment of phagocytic killing by neutrophils. Blood 90(10 Suppl 1 Pt 2): 43B

Higazi, A.A.R.of; Ganz, T.; Kariko, K.; Cines, D. 1996: Defensin modulates tPA and plasminogen binding to fibrin and endothelial cells. Fibrinolysis 10(Suppl 3): 33

Mallow, E.B.; Bevins, C.L. 1994: Defensin-6 Structure of a small-intestinal antimicrobial peptide gene. Pediatric Research 35(4 Part 2): 239A

Gorter, A.D.; Eijk, P.P.; Van Wetering, S.; Dankert, J.; Hiemstra, P.S.; Van Alphen, L. 1997: Defensin-mediated adherence of Haemophilus influenzae to human airway epithelial cells. European Respiratory Journal Suppl 10(25): 456S

Ganz, T.; Selsted, M.E.; Lehrer, R.I. 1990: Defensins. European Journal of Haematology 44(1): 1-8

Burnett, D. 1992: Defensins: ancient but potentially dangerous weapons in the armoury. Thorax 47(3): 195-196

Yuan, J.; Banaiee, N.; Selsted, M.E. 1996: Defensins are expressed in mucosa of the female reproductive tract. Journal of Investigative Medicine 44(3): 220A

Mannis, M.J.; Schwab, I.R.; Dries, D.; Cullor, J.; Smith, W.; Reid, T.; Murphy, C.J. 1991: Defensins as a preservative in corneal storage medium. IOVS Investigative Ophthalmology and Visual Science 32(4): 1062

Selsted, M.E. 1989: Defensins biocidal activities and mechanistic models. Abstracts of Papers American Chemical Society 197: AGRO 15

Selsted, M.E.; Ouellette, A.J. 1995: Defensins in granules of phagocytic and non-phagocytic cells. Trends in Cell Biology 5(3): 114-119

Nakashima, H.; Yamamoto, N.; Masuda, M.; Fujii, N. 1993: Defensins inhibit HIV replication in vitro. Aids 7(8): 1129

Tkachenko, S.; Ashmarin, I.; Kubatiev, A.; Korneva, E.; Kokryakov, V. 1994: Defensins of human neutrophils inhibit agonist-induced intraplatelet calcium increase. Neuropeptides 26(Suppl 1): 66-67

Selsted, M.E. 1989: Defensins purification structure and synthesis. Abstracts of Papers American Chemical Society 197: AGRO 14

Ganz, T.; Selsted, M.E.; Lehrer, R.I. 1989: Defensins recent insights into their structure function and genetics. European Journal of Clinical Investigation 19(2 Part 2): A58

Nygaard, S.D.; Ganz, T.; Peterson, M.W. 1991: Defensins reduce barrier integrity of a cultured epithelial monolayer. American Review of Respiratory Disease 143(4 Part 2): A770

Shimoda, M.; Ohki, K.; Kohashi, O. 1995: Defensins, antimicrobial peptides, and their mechanism of actions. Nihon Saikingaku Zasshi. Japanese Journal of Bacteriology 50(2): 471-480

Ganz, T. 1997: Defensins-antimicrobial and proinflammatory peptides of phagocytes and epithelia. Journal of Leukocyte Biology (Suppl ): 17

Nadasy, G.L.; Jednakovits, A.; SzentivanyiM.Jr; Toth, M.; Kopcsanyi, V.; Szirmai, L.; Monos, E. 1996: Defensive action of BRLP-42 against diabetic changes in vascular mechanics of streptozotocin treated spontaneously hypertensive rats. International Angiology 15(2 Suppl 1): 21

Takahashi, Y.ko; Burke, Robert; Dan Sohkawa, Marina; Kaneko, Hiroyuki 1998: Defensive activities of mesenchyme cells against dissociated epithelial cells injected into blastocoel of the starfish larvae. Zoological Science 15(Suppl ): 71

Blanchard, D.C.; Hebert, M.A.; Henrie, J.A.; Sakai, R.R.; Blanchard, R.J. 1997: Defensive behavior change in socially stressed rats. Society for Neuroscience Abstracts 23(1-2): 1320

Kalin, N.H. 1991: Defensive behavior in nonhuman primates. Brown, M R , G F Koob And C Rivier (Ed ) Stress: Neurobiology And Neuroendocrinology Xii+706p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 359-374

Quinn, C.; Benjamin, D.; Pohorecky, L.A. 1995: Defensive behavior increases MAO-A activity in the locus coeruleus of the rat. Society for Neuroscience Abstracts 21(1-3): 2091

Aoki, S.; Kurosu, U.; Makino, S.'ichi 1996: Defensive behavior of the gall aphid Epipemphigus niisimae , with notes on the secondary host. Japanese Journal of Entomology 64(3): 636-640

Bertani, R.; Marques, O.A.gusto Vuolo 1996: Defensive behaviors in mygalomorph spiders Release of urticating hairs by some Aviculariinae. Zoologischer Anzeiger 234(3): 161-165

Yudko, E.B.; Agnes, R.; Hall, S.A.; Mccluskey, M.; Blanchard, R.J.; Blanchard, D.C. 1995: Defensive behaviors in the mouse Comparison to rat patterns. Society for Neuroscience Abstracts 21(1-3): 447

Blanchard, R.J. 1994: Defensive behaviour and clinical psychopathology. Acta Neurobiologiae Experimentalis 54(3): 270

Araujo, M., S.; Martins, M. 2000: Defensive behaviour in pit vipers of the genus Bothrops Serpentes, Viperidae. Herpetological Journal 16(3): 297-303

Treit, D. 1991: Defensive burying a pharmacological animal model for specific fears. Soubrie, P (Ed ) Animal Models Of Psychiatric Disorders, Vol 3 Anxiety, Depression, And Mania V+134p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 1-19

Sandbak, T.; Murison, R.; Sarviharju, M.; Hyytia, P. 1998: Defensive burying and stress gastric erosions in AA and ANA rat lines. Alcoholism Clinical and Experimental Research 22(3 ABSTR Suppl ): 194A

Nano, R.; Civallero, M.; Melchioni, C.; Lorusso, L.; Ceroni, M.; Capelli, E. 1995: Defensive cells presence in glioblastoma Significance and role. Anticancer Research 15(5A): 1815

Henningsson, M.; Sundbom, E. 1996: Defensive characteristics in individuals with amalgam illness as measured by the percept-genetic method Defense Mechanism Test. Acta Odontologica Scandinavica 54(3): 176-181

Horowitz, M.J. 1995: Defensive control of states and person schemas. Shapiro, T, Emde, R N Research in Psychoanalysis: Process, development, outcome 67-89

Boletzky, S.V. 1994: Defensive folding response in the shortfin squid, Illex coindetii. Veliger 37(3): 280-283

Harumoto, T.; Miyake, A. 1994: Defensive function of pigment granules in Stentor. Zoological Science 11(Suppl ): 24

Harumoto, T.; IIo, H.; Zenfuku, K.; Miyake, A. 1995: Defensive function of the red pigment in Blepharisma japonicum. European Journal of Protistology 31(4): 433

Sugibayashi, R.; Harumoto, T. 1998: Defensive function of trichocysts in Paramecium against a variety of predatory protozoa. Zoological Science 15(Suppl ): 25

Zeng, X.P.; Scicchitano, R.; Reynolds, P.; Holmes, M. 1998: Defensive gene expression is elevated in airway epithelium in chronic bronchitis. European Respiratory Journal 12(Suppl 28): 398S

Carlson, B.A.; Nolen, T.G. 1997: Defensive ink of Aplysia activates dactyl chemoreceptors of the predatory crab cancer. Society for Neuroscience Abstracts 23(1-2): 1072

Kania, G. 1994: Defensive mechanism of millipedes. Przeglad Zoologiczny 38(3-4): 201-214

Jans, D.; Dubois, P.; Jangoux, M. 1996: Defensive mechanisms of holothuroids Formation, role, and fate of intracoelomic brown bodies in the sea cucumber Holothuria tubulosa. Cell and Tissue Research 283(1): 99-106

Malinowski,H. 2008: Defensive mechanisms of woody plants against harmful insects. Progress In Plant Protection: 1, 25-33

Cantor, N.; Norem, J.K. 1989: Defensive pessimism and stress and coping. Social Cognition 7(2): 92-112

Blanchard, R.J.; Blanchard, D.C. 1996: Defensive quiescence to social stress Relationship to other immobile defenses. Society for Neuroscience Abstracts 22(1-3): 1138

Lockey, T.D.; Ourth, D.D. 1997: Defensive response to bacterial vaccination of phenoloxidase, prophenoloxidase, cecropin and lysozyme in hemolymph of Heliothis virescens larvae. Abstracts of the General Meeting of the American Society for Microbiology 97: 250

Smith, K.S.; Goodwin, G.A.; Barr, G.A. 1997: Defensive responses and the periaqueductal gray The role of mu-opioid receptors in early development of the rat. Society for Neuroscience Abstracts 23(1-2): 1085

Shuhama, R.; Del-Ben, C.M.; Loureiro, S.R.; Graeff, F.G. 2008: Defensive responses to threat scenarios in Brazilians reproduce the pattern of Hawaiian Americans and non-human mammals. Brazilian Journal of Medical and Biological Research 41(4): 324-332

Mckeehen, J.D.; Schraut, C.M.; Fulcher, R.G. 1998: Defensive role for cell wall phenolic acids during grain development. Cereal Foods World 43(7): 533

Martens, S.N.; Boyd, R.S. 1990: Defensive role of nickel hyperaccumulation by plants a field experiment. Bulletin of the Ecological Society of America 71(2 Suppl): 239

Thipyapong, P.; Steffens, J.C. 1996: Defensive role of polyphenol oxidases against Pseudomonas syringae pv tomato. Plant Physiology (Rockville) 111(2 Suppl): 168

Tomaschko, Karl Heinz 1994: Defensive secretion of ecdysteroids in Pycnogonum litorale. Zeitschrift fuer Naturforschung Section C Biosciences 49(5-6): 367-371

Steinbauer, M.J.; Davies, N.W. 1995: Defensive secretions of Amorbus obscuricornis , A rubiginosus and Gelonus tasmanicus. Journal of the Australian Entomological Society 34(1): 75-78

Dlott, J.W.; Daane, K.M. 1993: Defensive strategies and their impact on survival of Anaria lineatella and Grapholita molesta larvae to ant predation. Bulletin of the Ecological Society of America 74(2 Suppl): 216

Boeve, J.L. 1994: Defensive strategies in sawfly larvae against predators. Revue Suisse de Zoologie 101(4): 850

Crost, N.W.; Pauls, C.A.; Wacker, J. 2008: Defensiveness and anxiety predict frontal EEG asymmetry only in specific situational contexts. Biological Psychology 78(1): 43-52

Jorgensen, R.S.; Filipowski, D.M.; Gelling, P.D.; Langer, A.W. 1991: Defensiveness and low levels of disclosed type a behavior and anger repressive coping and the discrepancy between cardiovascular and affective responsivity. Psychophysiology 28(3A): S8

Paraskevaidis, I.A.; Nikolaidis, T.; Iliodromitis, E.K.; Vlahakos, D.; Tsiapras, D.; Mihalis, A.; Kremastinos, D.T. 1996: Deferioxamine infusion protects myocardium against post-bypass reperfusion injury. European Heart Journal 17(ABSTR Suppl ): 101

Ablin, J.; Shalev, O.; Karmeli, F.; Rachmilewitz, D. 1997: Deferiprone , an oral iron chelator - A novel approach to ameliorate gastric damage. Gastroenterology 112(4 Suppl): A52

Ablin, J.; Shalev, O.; Karmeli, F.; Rachmilewitz, D. 1997: Deferiprone , an oral iron chelator A novel approach to ameliorate experimental colitis. Gastroenterology 112(4 Suppl): A918

Loebstein, R.; Zahid, N.; Diav Citrin, O.; Atanackovic, G.; Uetrecht, J.; Koren, G. 1997: Deferiprone -induced agranulocytosis A possible mechanism. Clinical Pharmacology and Therapeutics 61(2): 139

Newfield, R.S.; Walker, P.; Grady, R.W.; Hanauske Abel, H.M. 1996: Deferiprone An in vitro inhibitor of protein hydroxylases vital for matrix formation and cell proliferation. Pediatric Research 39(4 Part 2): 160A

Grady, R.W.; Hilgartner, M.W.; Giardina, P.J. 1996: Deferiprone Its efficacy relative to that of desferal. Blood 88(10 Suppl 1 Part 1-2): 310A

Shalev, O.; Choong, S.; Goldfarb, A.; Abrahamov, A.; Rachmilewitz, E.A.; Hebbel, R.P. 1998: Deferiprone attenuates methemoglobin formation in metabolically-stressed normal and beta-thalassemic RBC. Blood 92(10 Suppl 1 Part 1-2): 529A

Popelová, O.; Sterba, M.; Simůnek, T.ás.; Mazurová, Y.; Guncová, I.; Hroch, M.; Adamcová, M.; Gersl, V.ír. 2008: Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo. Journal of Pharmacology and Experimental Therapeutics 326(1): 259-269

Hershko, C.; Link, G.; Pinson, A.; Konijn, A.M. 1997: Deferiprone fails to mobilize iron and promotes iron cardiotoxicity at suboptimal L1/iron concentrations. Blood 90(10 Suppl 1 Pt 1): 11A

Hung, O.; Manoach, S.; Howland, M.A.; Rohera, B.; Goldfrank, L.; Hoffman, R. 1997: Deferiprone from acute iron poisoning. Journal of Toxicology. Clinical Toxicology 35(5): 565

D.F.anceschi, L.; Shalev, O.; Piga, A.; Collell, M.; Olivieri, O.; Corrocher, R.; Hebbel, R.P.; Olivieri, N.; Brugnara, C. 1996: Deferiprone treatment removes erythrocyte membrane free iron and affects K-Cl cotransport activity in homozygous beta thalassemia. Blood 88(10 Suppl 1 Part 1-2): 24B

Newfield, R.S.; Giardina, P.J.; Grady, R.W.; Hanauske Abel, H.M. 1996: Deferiprone, but not deferoxamine, inhibits biosynthesis of fibrillar procollagens in iron-overloaded thalassemia patients. Pediatric Research 39(4 Part 2): 160A

Iliodromitis, E.; Paraskevaidis, I.; Bouris, I.; Tsetsos, G.; Matsakas, E.; Papadopoulos, C.; Rentoukas, E.; Kremastinos, D.T. 1993: Deferoxamine administration and postischemic recovery in acute myocardial infarction. Cardiovascular Drugs and Therapy 7(Suppl 2): 426

Paraskevaidis, I.A.; Vlahakos, D.; Nikolaidis, T.; Tsiapras, D.; Marathias, K.; Roboli, S.; Yatzidis, H.; Iliodromitis, E.; Kremastinos, D.T. 1997: Deferoxamine ameliorates oxygen free radical production and protects myocardium against post-bypass reperfusion injury. European Heart Journal 18(ABSTR Suppl ): 659

Rana, M.W.; Ali, M.A.; Chang, Y.; Taylor, W.; Shapiro, M.J. 1997: Deferoxamine and Hespan as a resuscitative adjuvant in a rat hemorrhagic shock model. FASEB Journal 11(3): A286

Kawamoto, S.; Kawamura, T.; Takahashi, T.; Mitarai, T.; Sakai, O. 1996: Deferoxamine attenuates early glomerular infiltration of macrophages and prevents late glomerular injury in puromycin aminonucleoside nephropathy. Journal of the American Society of Nephrology 7(9): 1736-1737

Katoh, S.; Koike, A.; Akita, T.; Abe, T.; Kodama, I.; Toyama, J. 1992: Deferoxamine attenuates reperfusion injury of langendorff perfused neonatal hearts after hypothermic preservation. Journal of Molecular and Cellular Cardiology 24(Suppl 1): S167

Schapira, R.M.; Osornio, A.R.; Ghio, A.J.; Kennedy, T.P.; Brody, A.R. 1990: Deferoxamine attenuates secretion of platelet derived growth factor by alveolar macrophages exposed to asbestos in vitro. American Review of Respiratory Disease 141(4 Part 2): A414

Ihnken, K.; Morita, K.; Buckberg, G.D.; Winkelmann, B.; Young, H.; Beyersdorf, F. 1995: Deferoxamine avoids reoxygenation injury in immature cyanotic hearts. Circulation 92(8): I52

Frantz, C.N.; Eskenazi, A.E.; Overman, D.; Fan, L. 1996: Deferoxamine combined with chemotherapy drugs Effects on L1210 leukemia cells in vitro. Blood 88(10 Suppl 1 Part 1-2): 147B

Mergner, G.W.; Kramer, J.H.; Stolte, A.S.; Liang J H.; Weglicki, W.B. 1990: Deferoxamine decreases free radical production in the regionally ischemic swine heart. Circulation 82(4 Suppl 3): III700

Weinstein, G.S.; Maves, M.D.; McCormack, M.L. 1989: Deferoxamine decreases necrosis in dorsally based pig skin flaps. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 101(5): 559-561

Ornstein, D.L.; Zacharski, L.R. 1996: Deferoxamine decreases steady-state levels of urokinase type plasminogen activator mRNA and protein in cultured human prostate cancer cell line, PC-3. Blood 88(10 Suppl 1 Part 1-2): 69B

Papazisis, G.; Pourzitaki, C.; Sardeli, C.; Lallas, A.; Amaniti, E.; Kouvelas, D. 2008: Deferoxamine decreases the excitatory amino acid levels and improves the histological outcome in the hippocampus of neonatal rats after hypoxia-ischemia. Pharmacological Research 57(1): 73-78

Jacobsohn, E.; Löwe, H. 1992: Deferoxamine (Desferal) improves the content of oxygen in myocardial tissues during recovery after hypoxia in isolated rabbit heart. Die Pharmazie 47(5): 381-383

Brancaccio D.; Avanzini G.; Padovese P.; Panzica F.; Gallieni M.; Anelli A.; Franceschetti S.; Colantonio G.; Martinelli D.; Et Al 1990: Deferoxamine dfo infusion can induce eeg abnormalities in hemodialyzed hd patients. Kidney International 37(1): 289

Leblanc, M.H.; Feng, Y.Z.; Parker, C.C.; Fratkin, J.D. 1998: Deferoxamine does not affect the severity of hypoxic ischemic brain injury in the piglet. Society for Neuroscience Abstracts 24(1-2): 214

Tielemans, C.; Boelaert, J.; Vergauwe, P.; van Roost, G.; Segaert, M.; van Frachen, B.; Lenclud, C. 1989: Deferoxamine does not increase the risk for bacteremia in hemodialysis patients. Nephron 53(3): 276-277

Nakamura, H.; del Nido, P.J.; Jimenez, E.; Sarin, M.; Levitsky, S.; Feinberg, H. 1990: Deferoxamine fails to improve postischemic cardiac function in hypertrophied hearts. Circulation 82(5): Iv328-Iv331

Reddy, B.R.; Wynne, J.; Kloner, R.A.; Przyklenk, K. 1989: Deferoxamine fails to provide sustained protection against ischemia reperfusion injury. Circulation 80(4 Suppl 2): II239

Matsuoka, S.; Kobayashi, M.; Shimizu, H.; Suzuki, K.; Funaki, K.; Kumagai, H.; Ikeda, S.; Miura, M. 1992: Deferoxamine improves the efficiency of myocardial oxygen consumption in stunned myocardium. Journal of Molecular and Cellular Cardiology 24(Suppl 1): S153

Donfrancesco, A.; De Sio, L.; De Laurentis, Fidani P.; Cozza, R.; Castelanno, A.; Deb, G. 1996: Deferoxamine in tumor therapy. Experimental Hematology 24(9): 1112

Yoo, Y-Bum.; Lee, K.Ryong.; Kim, S-Whan.; Kwon, K.; Goo, T-Won.; Kwon, O-Yu. 2008: Deferoxamine induces endoplasmic reticulum stress in PC12 cells. Zeitschrift für Naturforschung. C Journal of Biosciences 63(3-4): 308-310

Becton, D.L.; Roberts, B.; Bryles, P. 1990: Deferoxamine inhibition of proliferation and dna synthesis in human myeloid leukemia cell lines. Clinical Research 38(1): 60A

Voest, E.E.; Van Asbeck, B.S.; Neijt, J.P.; Marx, J.J.M. 1993: Deferoxamine inhibits adriamycin-induced cardiotoxicity in the rat. Clinical Research 41(2): 309A

Park, T.S.; Beetsch, J.W.; Gonzales, E.R.; Shah, A.R.; Maceren, R.G.; Lee, Y.B.; Gehlbach, P.L.; Gidday, J.M. 1996: Deferoxamine inhibits asphyxia-induced increases in leukocyte adherence and vascular permeability. Society for Neuroscience Abstracts 22(1-3): 2143

Gotchall, J.I.; Moseley, P.L. 1989: Deferoxamine inhibits bleomycin at the cell surface. Clinical Research 37(4): 948A

Tomoyasu, S.; Suzuki, K.; Tsuruoka, N. 1990: Deferoxamine inhibits cell growth and changes c myc expression in hl 60 cells. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 7

Katz, B.; Gately, S.; Takano, S.; Engelhard, H.; Brem, S. 1993: Deferoxamine inhibits tumor and endothelial cell growth in vitro. Proceedings of the American Association for Cancer Research Annual Meeting 34: 375

Frantz, C.N.; Eskenazi, A.E.; Overman, D.; Fan, L. 1996: Deferoxamine iron chelation therapy for childhood cancer. Experimental Hematology 24(9): 1112

Voest, E.E.; Van Asbeck, B.S.; Neijt, J.P.; Nortier, J.W.R.; Marx, J.J.M. 1991: Deferoxamine iron sorbitol citrate and doxorubicin combination therapy preliminary results of a phase i trial. European Journal of Clinical Investigation 21(2 Part 2): 58

Hershko, C.; Link, G.; Tirosh, R.; Pinson, A. 1996: Deferoxamine prevents anthracycline cardiotoxicity Role of iron in mitochondrial injury. Blood 88(10 Suppl 1 Part 1-2): 71A

Lamping K.G.; Nuno D.W.; De Bruyn V.H. 1989: Deferoxamine prevents augmented large coronary artery constriction to serotonin following acute hypertension. FASEB Journal 3(4): A973

Heim, K.F.; Fomsgaard, J.S.; Danchak, R.M.; Thomas, G.; Ramwell, P.W.; Kim, Y.D. 1992: Deferoxamine prevents dysfunction of canine coronary endothelium following brief ischemia. Journal of the American College of Cardiology 19(3 Suppl A): 191A

Caraceni, P.; Gasbarrini, A.; Bernardi, M.; Gasbarrini, G.; Borle, A.B.; Van Thiel, D.H. 1993: Deferoxamine prevents reoxygenation injury and lipid peroxidation in rat hepatocytes by two different mechanisms. Journal of Hepatology 18(Suppl 1): S48-S49

Gorry, M.; Rinaldo, J. 1989: Deferoxamine protects against endotoxin induced injury to cultured lung endothelial cells. American Review of Respiratory Disease 139(4 Part 2): A423

Guy, J.; Fitzsimmons, J.; Rao, N. 1994: Deferoxamine reduces BBB disruption in experimental optic neuritis. IOVS Investigative Ophthalmology and Visual Science 35(4): 1514

Shadid, M.; Dorrepaal, C.A.; Steendijk, P.; Hilterman, L.; Berger, H.M.; Baan, J.; Van Bel, F. 1996: Deferoxamine reduces cerebral reperfusion injury after birth asphyxia. Pediatric Research 39(4 Part 2): 381A

Sokol, R.J.; Devereaux, M.W.; Khandwala, R.A.; Shikes, R. 1990: Deferoxamine reduces cholestatic and oxidative hepatic injury in bile duct ligated rats. Hepatology 12(4 Part 2): 894

Katoh, S.; Akita, T.; Abe, T.; Kamiya, K.; Kodama, I.; Toyama, J. 1991: Deferoxamine reduces myocardial injury and free radical generation in isolated neonatal rabbit hearts subjected to global ischemia reperfusion. Circulation 84(4 Suppl 2): II255

Rose, C.; Cambie, C.; Mahieu, M.; Forzy, G.; Demory, J.L.; Jouet, J.P.; Bauters, F.; Fenaux, P. 1997: Deferoxamine stability in common intravenous solutions. Blood 90(10 Suppl 1 Pt 2): 18B-19B

Rose, C.; Cambié, C.; Forzy, G.; Mahieu, M.; Fenaux, P.; Bauters, F. 1998: Deferoxamine stability in intravenous solution. Annals of the new York Academy of Sciences 850: 488-489

Palmer, C.; Roberts, R.L. 1997: Deferoxamine starch conjugate provides partial protection from hypoxic-ischemic brain injury in neonatal rats. Pediatric Research 41(4 Part 2): 294A

Lens, X.M.; Alonso, R.; Martin, C.; Arcocha, V.; Correa, B.; Arza, D.; Alonso, C.; Novoa, D.; Romero, R.; Sanchez Guisande, D. 1993: Deferoxamine test Can dose be reduced?. Bone (New York) 14(1): 73

Becker, J.; Sarco, D.; Fullerton Chetkovich, H.; Sheldon, R.A.; Ferriero, D. 1998: Deferoxamine therapy in a mouse model of neonatal brain hypoxia-ischemia. Journal of Investigative Medicine 46(1): 96A

Vaskaridou, E.; Konstantopoulos, K.; Kyriakou, D.; Loukopoulos, D. 1993: Deferoxamine treatment during early pregnancy: absence of teratogenicity in two cases. Haematologica 78(3): 183-184

Khoury, S.; Odeh, M.; Oettinger, M. 1995: Deferoxamine treatment for acute iron intoxication in pregnancy. Acta Obstetricia et Gynecologica Scandinavica 74(9): 756-757

Mehta, A.M.; Engstrom, R.E.; Kreiger, A.E. 1994: Deferoxamine-associated retinopathy after subcutaneous injection. American Journal of Ophthalmology 118(2): 260-262

Mackinnon, J.A.; Basran, R.K.; Belluzzo, N.; Babyn, P.; Chuang, S.; Chiu, L.; Bailey, J.D.; Olivieri, N.F. 1994: Deferoxamine-induced metaphyseal and spinal abnormalities in patients with diamond-blackfan anemia. Blood 84(10 Suppl 1): 117A

Sher, G.D.; Muraca, M.; Scott, J.G.; Buncic, J.R.; Brittenham, G.M.; Olivieri, N.F. 1994: Deferoxamine-induced visual toxicity in two unique clinical settings The importance of ongoing assessment of body iron burden. Blood 84(10 Suppl 1): 258A

Douglas, D.; Smilkstein, M. 1995: Deferoxamine-iron induced pulmonary injury and N-acetylcysteine. Journal of Toxicology. Clinical Toxicology 33(5): 495

Baath, J.S.; Lam, W-Ching.; Kirby, M.; Chun, A. 2008: Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population. Retina 28(6): 894-899

Gotchall, J.I.; Moseley, P.L. 1991: Deferoxamines ability to reduce bleomycin cytotoxicity varies by cell line. Clinical Research 39(3): 751A

Droste, H.T.; De Bruyne, B.; Bech, G.J.W.; Michels, H.R.; Koolen, J.J.; Pijls, N.H.J. 1997: Deferral of bypass surgery in equivocal left main disease, based upon coronary pressure measurements. European Heart Journal 18(ABSTR Suppl ): 239

Newman, B.H.; Haperin, D.M.; Baetens, J.S. 1996: Deferral of tattooed donors The effect on future blood donations and the incidence of seromarkers upon return A case-controlled pilot study. Transfusion 36(9 Suppl): 3S

Cox, C.D. 1994: Deferration of laboratory media and assays for ferric and ferrous ions. Methods in Enzymology 235: 315-329

Crosa, J.H. 1995: Deferration using anguibactin siderophore. Official Gazette of the United States Patent and Trademark Office Patents 1171(4): 2595

Baudelot, J. 1995: Deferred autologous blood collection in 1995. Nouvelle Revue Francaise d'Hematologie 37(Suppl 1): S9-S10

Kple Faget, P.; Aboudiab, T.; Cabaud, J.J. 1994: Deferred autologous transfusion Three-year survey at the Blood Transfusion Service of Saint-Quentin. Afrique Medicale 33(312): 125-129

Baron, J.F. 1995: Deferred autologous transfusion and erythropoietin. Nouvelle Revue Francaise d'Hematologie 37(Suppl 1): S17-S25

Kourouma,K.; Diallo,M.S.; Diallo,F.B.; Kamano,M. 2008: Deferred autologous transfusions in pregnant women scheduled for caesareans. Medecine D'Afrique Noire: 7, 381-385

Barnat, S.B.; Klein, P.J.; Meltzoff, A.N. 1996: Deferred Imitation Across Changes in Context and Object: Memory and Generalization in 14-Month-Old Infants. Infant Behavior and Development 19(2): 241-251

Bering, J.M.; Bjorklund, D.F.; Ragan, P. 1998: Deferred imitation of object-related actions in young, enculturated great apes. American Journal of Primatology 45(2): 170

Smith, P.H. 1993: Deferred therapy in patients with advanced disease. Cancer 71(3 Suppl): 1074-1077

Adolfsson, J.; Steineck, G.; Hedlund, P.O.ov 1998: Deferred treatment of clinically localized low-grade prostate cancer Actual 10 years and projected 15 years follow-up of the Karolinska series. Journal of Urology 159(5 Suppl): 252

Dighiero, G.; Chevret, S.; Piguet, H.; Maloum, K.; Desablens, B.; Fenaux, P.; Pignon, B.; Navarro, M.; Leblay, R.; Leporrier, M.; Jaubert, J.; Colombat, P.; Vaugier, G.; Lepeu, G.; Turpin, F.; Meffre, D.; Claisse, J.F.; Cazin, B.; Binet, J.L.; Chastang, C.; Travade, P. 1997: Deferred versus early therapy with chlorambucil in stage A CLL patients Long term results from two randomized trials of the French Cooperative Group in CLL. Blood 90(10 Suppl 1 Pt 1): 578A

Audebert, A.J.; Madenelat, P.; Querleu, D.; Pontonnier, G.; Racinet, C.; Renaud, R.; Gillet, J.Y.; Raudrant, D.; Lansac, J.; Brettes, J.P. 1994: Deferred versus immediate surgery for uterine fibroids: clinical trial results. British Journal of Obstetrics and Gynaecology 101(Suppl 10): 29-32

Lee, D.S.C.; Chau, T.A.I. 1993: Deferrioxamine inhibits the effect of tert-butyl-hydroperoxide on prostacyclin synthesis in perinatal rat lung cells. FASEB Journal 7(3-4): A674

Gratadour, P.; Fouque, D.; Chevalier, P.; Vial, T.; Chossegros, P.; Laville, M.; Labeeuw, M.; Zech, P. 1992: Deferrioxamine-induced acute hepatitis during chronic hemodialysis. Therapie 47(6): 555

Erez, M.; Neuman, M.; Varon, D.; Manoach, M. 1989: Defibrillating agents a new class in antiarrhythmic classifications. Pfluegers Archiv European Journal of Physiology 413(Suppl 1): R7

Hampele, R.; Kraemer, M. 1998: Defibrillating device equipped with a plurality of connector/electrode assemblies of different types. Official Gazette of the United States Patent and Trademark Office Patents 1207(1): 297-298

Cansell, A. 1989: Defibrillating or cardioverting electric shock system including electrodes us patent 4825871 may 2 1989. Official Gazette of the United States Patent and Trademark Office Patents 1102(1): 145

Dillon, S.M. 1990: Defibrillating shocks cause nearly constant repolarization time in rabbit hearts. Circulation 82(4 Suppl 3): III640

Ito, M.; Pride, H.P.; Zipes, D.P. 1992: Defibrillating shocks delivered to the heart impair sympathetic responsiveness. Circulation 86(4 Suppl 1): I793

Rogove, H.J.; Hughes, C.M. 1992: Defibrillation and cardioversion. Critical Care Clinics 8(4): 839-863

Yomtov, B.M.; Finch, D.P. 1996: Defibrillation and method for cardioverting a heart and storing related activity data. Official Gazette of the United States Patent and Trademark Office Patents 1187(1): 279

Karagueuzian, H.S.; Chen, P S. 1998: Defibrillation apparatus and method. Official Gazette of the United States Patent and Trademark Office Patents 1215(1): 445-446

Block, M.; Seidl, K.; Asfour, B.; Isgro, F.; Werling, C.; Martinez Rubio, A.; Hauer, B.; Breithardt, G. 1996: Defibrillation between an active can and a right ventricular electrode can be improved by addition of a subcutaneous array electrode. European Heart Journal 17(ABSTR Suppl ): 479

Wright, D.; James, C.; Marsden, A.K.; Mackintosh, A.F. 1989: Defibrillation by ambulance staff who have had extended training. Bmj 299(6691): 96-97

Nikolic, G. 1996: Defibrillation conundrum. Heart and Lung: the Journal of Critical Care 25(6): 495-496

Natale, A.; Kearney, M.M.; Brandon, M.J.; Kent, V.; Fain, E.; Newby, K.H. 1996: Defibrillation efficacy of different defibrillator cases sizes in patients How small is too small?. Journal of the American College of Cardiology 27(2 Suppl A): 264A

Jung, W.; Manz, M.; Moosdorf, R.; Schneider, C.; Luederitz, B. 1992: Defibrillation efficacy of simultaneous monophasic and biphasic waveforms in man. Journal of the American College of Cardiology 19(3 Suppl A): 163A

Hirschberg, J.; Neubauer, H.; Gilljam, N.; Bowald, S. 1995: Defibrillation electrode. Official Gazette of the United States Patent and Trademark Office Patents 1172(2): 998

Mar, C.E. 1998: Defibrillation electrode connection. Official Gazette of the United States Patent and Trademark Office Patents 1210(1): 255

Lau, C.P.; Tse, H.F.; Ayers, G.M. 1998: Defibrillation guided mapping and radiofrequency ablation of focal atrial fibrillation. Journal of the American College of Cardiology 31(2 Suppl A): 61A

Guse, P.; Alferness, C.; Melnick, S.; Ideker, R. 1991: Defibrillation in dogs using multiple internal catheters apical and thoracic patch electrodes. FASEB Journal 5(6): A1743

Guse, P.A.; Rollins, D.L.; Afework, Y.; Dixon Tulloch, E.; Ideker, R.E. 1992: Defibrillation in pigs using a triphasic waveform comparison with biphasic and sequential biphasic waveforms. Journal of the American College of Cardiology 19(3 Suppl A): 163A

Bussey, J.G.IIi; Calure, J.A.; Wise, R.M.; Bhora, F.Y.; Foster, A.H. 1998: Defibrillation induced vasospasm is reduced by nitric oxide. Journal of Molecular and Cellular Cardiology 30(6): A36

Mar, C.E.; Bush, M.E.; Pless, B.D. 1995: Defibrillation lead with improved mechanical and electrical characteristics. Official Gazette of the United States Patent and Trademark Office Patents 1174(1): 289

Kenknight, B.H.; Hall, J.A. 1995: Defibrillation patch electrode having conductor-free resilient zone for minimally invasive deployment. Official Gazette of the United States Patent and Trademark Office Patents 1171(3): 1693

L.H.G.; Jones, D.L.; Yee, R.; Klein, G.J. 1992: Defibrillation shocks prolong refractoriness but elicit a bimodal effect on action potential duration of mammalian cardiac myocytes. Journal of the American College of Cardiology 19(3 Suppl A): 122A

Hahn, S.J.; Heil, J.E.; Lin, Y.; Lang, D.J. 1994: Defibrillation strength-duration relationships for fixed-tilt biphasic waveforms. Circulation 90(4 Part 2): I228

Hsia, P.W.; Fendelander, L.; Harrington, G.; Damiano, R.J. 1996: Defibrillation success is associated with myocardial organization. Spatial coherence as a new method of quantifying the electrical organization of the heart. Journal of Electrocardiology 29 Suppl: 189-197

Sweeney, M.B.; Echt, D.S. 1995: Defibrillation system having innominate vein electrode and method for its use. Official Gazette of the United States Patent and Trademark Office Patents 1170(4): 2383-2384

Sears, G.K.; Griffin, J.C. 1997: Defibrillation system including an atrial difibrillator and ventricular defibrillation backup. Official Gazette of the United States Patent and Trademark Office Patents 1205(3): 2077

Jones, D.L.; Klein, G.J. 1990: Defibrillation threshold a simple rapid and reliable assessment of the ability to defibrillate the heart. Clinical and Investigative Medicine 13(5 Suppl): C77

Montenero A.S.; Bombardieri G.; Barilaro C.; Di Francesco P.; Santarelli P.; Pisano E.; Possati G.F. 1990: Defibrillation threshold comparison between unidirectional and bidirectional monophasic shocks in pigs. European Heart Journal 11(ABSTR Suppl): 438

Stewart, A.; Allen, J.D.; Adgey, A.A.J. 1990: Defibrillation threshold estimation a useful measurement. Journal of Molecular and Cellular Cardiology 22(Suppl 3): S86

Ott, P.; Reiter, M.J. 1996: Defibrillation threshold in the isolated rabbit heart Effect of ventricular dilatation. Journal of the American College of Cardiology 27(2 Suppl A): 328A

Lucy, S.D.; Jones, D.L.; Klein, G.L. 1990: Defibrillation threshold is increased over time in a dog model of congestive heart failure. Clinical and Investigative Medicine 13(5 Suppl): C77

Callihan, R.L.; Dahl, R.W.; Idriss, S.F.; Wolf, P.D.; Smith, W.M.; Ideker, R.E. 1993: Defibrillation threshold measurements using an endocardial lead configuration with and without inactive epicardial patch in dogs. Circulation 88(4 Part 2): I592

Min, X.; Mongeon, L.R.; Hill, M.R.S. 1998: Defibrillation threshold reduction system. Official Gazette of the United States Patent and Trademark Office Patents 1207(1): 296

Sra, J.; Axtell, K.; Shalev, Y.; Tchou, P. 1989: Defibrillation threshold stability on long term follow up in patients with automatic implantable cardioverter defibrillator. Circulation 80(4 Suppl 2): II658

Vlay, S.C. 1989: Defibrillation threshold testing: necessary but evil?. American Heart Journal 117(2): 499-504

Leonelli, F.; Brewer, J.; Kroll, M.; Adams, T. 1995: Defibrillation threshold with optimized durations and a smaller capacitor in active can system. European Heart Journal 16(ABSTR Suppl ): 197

Natale, A.; Deshpande, S.; Budziszewski, M.; Solie, J.; Axtell, K.; Krum, D.; Sra, J.; Akhtar, M.; Samaritan, S. 1994: Defibrillation threshold with three different biphasic shapes incorporated in commercially available devices. Circulation 90(4 Part 2): I499

Kavanagh, K.M.; Guerrero, P.A.; Witkowski, F.X.; Jugdutt, B.I.; Jones, K.L. 1996: Defibrillation thresholds and changes in ventricular fibrillation morphology. Circulation 94(8): I715

Friedman, P.A.; Trusty, J.M.; Grice, S.K.; Stanton, M.S. 1998: Defibrillation thresholds are increased by right-sided implantation of totally transvenous active can devices. Journal of the American College of Cardiology 31(2 Suppl A): 334A

Block, M.; Hammel, D.; Boecker, D.; Isbruch, F.; Castrucci, M.; Fastenrath, C.; Budde, T.; Breithardt, G. 1994: Defibrillation thresholds are not improved if the anode is positioned in the left brachiocephalic vein instead of the low superior vena cava. European Heart Journal 15(ABSTR Suppl ): 346

Friedman, P.A.; Grice, S.; Espinosa, R.E.; Stanton, M.S. 1997: Defibrillation thresholds are significantly increased by a right-sided approach to totally transvenous implantable defibrillator systems placement. Journal of the American College of Cardiology 29(2 Suppl A): 472A

Prodafikas, J.; Wang, P.J.; Manolis, A.; Butts, L.; Colburn, C.; Cliff, D.; Gadhoke, A.; Estes, N.A.M.rk, IIi 1993: Defibrillation thresholds in non-thoracotomy defibrillator patients receiving amiodarone. Journal of the American College of Cardiology 21(2 Suppl A): 156A

Dutinth, V.; Schwartzman, D.; Callans, D.J.; Gottlieb, C.D.; Marchlinski, F.E. 1996: Defibrillation thresholds with monophasic versus biphasic shocks delivered through a single-lead endocardial defibrillation system. American Heart Journal 131(3): 611-613

Tang, A.S.L.; Min, X.; Bonner, M.; Mehra, R. 1997: Defibrillation using a RV apex or RV outflow lead combined with active CAN Human and modelling analysis. Journal of the American College of Cardiology 29(2 Suppl A): 434A

Sweeney, R.J.; Gill, R.M.; Jones, J.L.; Reid, P.R. 1995: Defibrillation using a series of high-frequency monophasic current pulses. Journal of the American College of Cardiology 1995(SPEC ISSUE): 85A

Sweeney, R.J.; Gill, R.M.; Reid, P.R. 1994: Defibrillation using biphasic rectangular waveforms. Circulation 90(4 Part 2): I446

Guse, P.A.; Walcott, G.P.; Melnick, S.B.; Ideker, R.E. 1991: Defibrillation using dual successive biphasic shocks importance of electrode number and location. Circulation 84(4): II610

Sweeney, R.J.; Gill, R.M.; Reid, P.R. 1996: Defibrillation using multiple pathway shocks with rotational field gradients. Journal of the American College of Cardiology 27(2 Suppl A): 146A-147A

Guse, P.A.; Dixon Tulloch, E.; Danieley, N.D.; Smith, W.M.; Ideker, R.E. 1993: Defibrillation using sequential pulsing Importance of phase reversal. Journal of the American College of Cardiology 21(2 Suppl A): 127A

Gray, R.A.; Jalife, J. 1998: Defibrillation utilizing the dominant frequency of fibrillation. Official Gazette of the United States Patent and Trademark Office Patents 1213(2): 1596

Uchiyama, H.; Hata, T.; Sadanaga, T.; Hasegawa, K.; Watanabe, Y. 1994: Defibrillation with adrenalin in isolated, perfused rabbit hearts. Japanese Heart Journal 35(Suppl 1): 167-168

Natale, A.; Newby, K.H.; Brandon, J.; Kearney, M.; Beheiry, S.; Henderson, P.H.; Wolverton, A.; Fanelli, R.; Pisalo, E. 1997: Defibrillation with different energy levels and during sleep Impact of pain perception. Journal of the American College of Cardiology 29(2 Suppl A): 195A

Halperin, H.; Leng, C.; Paradis, N.; Calkins, H.; Ireland, M.; Rent, K.; Berger, R. 1998: Defibrillation with monophasic and biphasic waveforms in prolonged cardiac arrest. Circulation 98(17): I173

Rubin, L. 1994: Defibrillator and demand pacer catheters and methods for using same. Official Gazette of the United States Patent and Trademark Office Patents 1169(3): 1620-1621

Post, W.L. 1997: Defibrillator and method for storing selected segments of audio data. Official Gazette of the United States Patent and Trademark Office Patents 1204(1): 300

Adams, J.M.; Alferness, C.A. 1995: Defibrillator and method utilizing three channel sensing. Official Gazette of the United States Patent and Trademark Office Patents 1173(1): 307

Lemole, G.M. 1996: Defibrillator charge tester. Official Gazette of the United States Patent and Trademark Office Patents 1190(2): 1123-1124

Benson, J.M. 1989: Defibrillator circuit for producing a trapezoidal defibrillation pulse us patent 4823796 april 25 1989. Official Gazette of the United States Patent and Trademark Office Patents 1101(4): 2310

Morgan, C.B. 1995: Defibrillator electrode system. Official Gazette of the United States Patent and Trademark Office Patents 1180(2): 912

Heath, R.L. 1989: Defibrillator electrode system us patent 4850356 july 25 1989. Official Gazette of the United States Patent and Trademark Office Patents 1104(4): 2348

Morgan, C.B. 1997: Defibrillator electrode system using a flexible substrate and having electrode test features. Official Gazette of the United States Patent and Trademark Office Patents 1197(2): 845

Stolte, J.F. 1997: Defibrillator electrodes and date code detector circuit. Official Gazette of the United States Patent and Trademark Office Patents 1205(3): 2077-2078

Mehra, R. 1995: Defibrillator employing transvenous and subcutaneous electrodes. Official Gazette of the United States Patent and Trademark Office Patents 1177(2): 893

Meltzer, M.J. 1997: Defibrillator having redundant switchable high voltage capacitors. Official Gazette of the United States Patent and Trademark Office Patents 1194(1): 289

Degroot, P.J.; Church, T.R.; Mehra, R. 1997: Defibrillator implant criteria based on probability of successful defibrillation. Allessie, M A, Fromer, M Bakken Research Center Series; Atrial and ventricular fibrillation: Mechanisms and device therapy: 355-372

Embil, J.; Geddes, J. 1992: Defibrillator implantation in an arc welder. Clinical and Investigative Medicine 15(4 Suppl): A79

Grey, T.C. 1989: Defibrillator injury suggesting bite mark. American Journal of Forensic Medicine and Pathology 10(2): 144-145

Myers, R.C. 1998: Defibrillator method and system for making post-discharge measurements of energy and impedance. Official Gazette of the United States Patent and Trademark Office Patents 1216(3): 2759

Flugstad, B.A. 1995: Defibrillator patient circuit. Official Gazette of the United States Patent and Trademark Office Patents 1177(4): 2353

Olsen, K.F.; Salvatori, P.H.; Powers, D.J. 1995: Defibrillator patient connection system with automatic identification. Official Gazette of the United States Patent and Trademark Office Patents 1177(3): 1635

Lindemans, F.W. 1997: Defibrillator physics for the physician. Allessie, M A, Fromer, M Bakken Research Center Series; Atrial and ventricular fibrillation: Mechanisms and device therapy: 373-397

Alt, E.; Stotts, L.J. 1996: Defibrillator shock timing in dibrillatory cycle interval. Official Gazette of the United States Patent and Trademark Office Patents 1192(4): 2722

Ziss, W.; Andresen, D.; Behrens, S.; Brueggemann, T.; Ehlers, C.; Schultheiss, H.P. 1995: Defibrillator shocks Relationship to time of day and physical activity. European Heart Journal 16(ABSTR Suppl ): 220

Morgan, C.B. 1997: Defibrillator system condition indictator. Official Gazette of the United States Patent and Trademark Office Patents 1194(1): 290

Morgan, C.B.; Powers, D.; Cole, C.; Mydynski, S.T.; Leventhal, M.J. 1997: Defibrillator system using multiple external defibrillators and a communications network. Official Gazette of the United States Patent and Trademark Office Patents 1194(2): 1068-1069

Schmidt, S.B.; Hill, R.C.; Lobban, J.H. 1994: Defibrillator twiddler syndrome producing lead fracture and inappropriate shocks. Clinical Research 42(2): 327A

Navone, A.; Picone, A.; Boahene, K. 1996: Defibrillator twiddler's syndrome: a rare cause of implantable cardioverter-defibrillator failure. Heart 76(5): 455-456

Swanson, D.K.; Nelson, J.P.; Lang, D.J. 1997: Defibrillator waveform generator for generating waveform of long duration. Official Gazette of the United States Patent and Trademark Office Patents 1199(1): 263

Cameron, D.B. 1995: Defibrillator with a high voltage solid state relay. Official Gazette of the United States Patent and Trademark Office Patents 1172(1): 294

Hirschberg, J.; Strandberg, H. 1995: Defibrillator with current limiter. Official Gazette of the United States Patent and Trademark Office Patents 1176(3): 1755

Sakai, Y.; Tsumura, I.; Kobayashi, N. 1994: Defibrillator with electrocardiogram monitor. Official Gazette of the United States Patent and Trademark Office Patents 1169(4): 2295

Hirschberg, J.; Strandberg, H. 1996: Defibrillator with output stage using switching network and three electrode. Official Gazette of the United States Patent and Trademark Office Patents 1193(3): 1942-1943

Karagueuzian, H.S.; Diamond, G.A.; Khan, S.S.; Denton, T.A.; Evans, S. 1997: Defibrillator with shock energy based on EKG transform. Official Gazette of the United States Patent and Trademark Office Patents 1200(1): 288

Cole, C.; Morgan, C.B.; Cyrus, J.; Powers, D. 1997: Defibrillator with training features and pause actuator. Official Gazette of the United States Patent and Trademark Office Patents 1202(1): 294-295

Brink, G.D. 1998: Defibrillator with waveform selection circuitry. Official Gazette of the United States Patent and Trademark Office Patents 1208(2): 1243

Hedberg, S E. 1994: Defibrillator/cardioverter. Official Gazette of the United States Patent and Trademark Office Patents 1169(4): 2295-2296

Böcker, D.; Block, M.; Borggrefe, M.; Breithardt, G. 1997: Defibrillators are superior to antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias. European Heart Journal 18(1): 26-30

Bril, A.; Faivre, J.F.; Landais, L.; Gout, B. 1992: Defibrillatory action of dofetilide and glibenclamide on reperfusion arrhythmias in the rat Blockade of the ATP-sensitive potassium channel as common mechanism. Journal of Molecular and Cellular Cardiology 24(Suppl 5): S68

Csonka, C.; Csont, T.; Szilvassy, Z.; Ferdinandy, P.; Tosaki, A. 1997: Defibrillatory action of the KATP-blocker glibenclamide involves an antioxidant mechanism in rat hearts. Journal of Molecular and Cellular Cardiology 29(5): A119

Bell, W.R. 1997: Defibrinogenating enzymes. Drugs 54 Suppl. 3: 18-30; Discussion 30-1

Kucher, K.; Mueller Peltzer, H.; Hornberger, W.; Maurer, R.; Noertersheuser, P.; Duebbers, K.; Velagapudi, R.; Faulkner, R.D. 1997: Defibrinogenation effects of ancrod following 3-hour intravenous infusion doses in healthy subjects. Clinical Pharmacology and Therapeutics 61(2): 144

Hong, M.K.; Aversano, T. 1989: Defibrinogenation reduces infarct size in a canine model of acute myocardial infarction. Journal of the American College of Cardiology 13(2 Suppl A): 125A

Levy, D.R.; Sujatta, M. 1995: Defibrinogenation with ancrod in the management of acute, ischemic stroke and heparin-induced thrombocytopenia. Biorheology 32(2-3): 165

Palmer, K.J.; Goa, K.L. 1993: Defibrotide. a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. Drugs 45(2): 259-294

Bianchi, G.; Alberico, P.; Tettamanti, R.; Mantovani, M.; Prino, G.; Rossoni, G.; Berti, F. 1991: Defibrotide, a prostacyclin releasing agent, protects the rabbit kidney from acute failure. Advances in Prostaglandin Thromboxane and Leukotriene Research 21b: 711-714

Coccheri, S.; Nazzari, M. 1996: Defibrotide as a possible anti-ischemic drug. Seminars in Thrombosis and Hemostasis 22(Suppl 1): 9-14

Abecasis, M.; Conceicao Silva, J.P.; Ferreira, I.; Guimaraes, A.; Machado, M. 1998: Defibrotide for liver veno-occlusive disease A case report. Blood 92(10 Suppl 1 Part 1-2): 319B

Hamblin, M.; Powles, R.; Treleaven, J.; Saso, R.; Singhal, S.; Middleton, G.; Kulkarni, S.; Cabral, S.; Mehta, J. 1996: Defibrotide for refractory thrombotic thrombocytopenic purpura after bone marrow transplantation. Blood 88(10 Suppl 1 Part 1-2): 60B

Hohlfeld, T. 1989: Defibrotide inhibits ischemia induced neutrophil activation in reperfused ischemic pig hearts. Naunyn-Schmiedeberg's Archives of Pharmacology 339(Suppl): R60

Biagi, G.; Rodorigo, G.; Coccheri, S. 1990: Defibrotide inhibits leukotriene b 4 production by neutrophils after oral medium term administration in man. Fibrinolysis 4(Suppl 1): 98

Hohlfeld, T.; Schroer, K. 1989: Defibrotide preserves regional contractility of stunned myocardium. Circulation 80(4 Suppl 2): II244

Ferrari, P.; Clerici, G.; Gussoni, G.; Nazzari, M. 1994: Defibrotide versus placebo in the treatment of intermittent claudication A meta-analysis. Drug Investigation 7(3): 157-160

Pescador, R.; Tettamanti, R.; Salvetti, L.; Conto, A.; Porta, R.; Mantovani, M.; Ferro, L. 1995: Defibrotide's activity on leukocytes and platelets in rabbits with diet-induced atherosclerosis. Agents and Actions. Supplements 45: 323-327

Magalhaes-Filho, J.-Rodrigues; Do-Amaral, L.-Rios; Sao-Pedro-Machado, D.-Favero; Medina, C.-Lazaro; Machado, E.-Caruso 2008: Deficiencia hidrica, trocas gasosas e crescimento de raizes em laranjeira Valencia sobre dois tipos de porta-enxerto. Bragantia 67(1): 75-82

Thriene, B.; Sobottka, A.; Schumann, G. 1998: Deficiencies and health risks of an unusual construction method for multiple dwellings with a compound framework. Zentralblatt fuer Hygiene und Umweltmedizin 201(1): 51-52

Vasiri Sani, F.; Jonsson, L.E.; Friess, H.; Berberat, P.; Hansson, L.; Buchler, M.W.; Andren Sanberg, A. 1998: Deficiencies and surpluses of elements in chronic pancreatitis tissue. Digestion 59(3): 239

Kelly Wintenberg, K.; El Alfy, A.; Montie, T.C. 1995: Deficiencies in OMP D-2 and Chemotaxis to Basic Amino Acids and Peptides in Pseudomonas aeruginosa. Abstracts of the General Meeting of the American Society for Microbiology 95: 265

Mcculloch, C.A.G.; Knowles, G.C. 1993: Deficiencies in collagen phagocytosis by fibroblasts as a mechanism for fibrosis. Journal of Dental Research 72(Special Issue): 293

Mcbride, W.J.; Chamberlain, J.K.; Chernet, E.; Bodart, B.; Lumeng, L.; Li, T.K. 1994: Deficiencies in dopamine and serotonin CNS systems associated with high alcohol preference. Society for Neuroscience Abstracts 20(1-2): 1615

D.S., F.J.; Luoh, S.M.; Carver Moore, K.; Ryan, A.; Dowd, M.; Eaton, D.L.; Moore, M.W. 1995: Deficiencies in early and late stages of megakaryocytopoiesis n TPO-KO mice. Blood 86(10 Suppl 1): 255A

Gimm, J.A.; Peters, L.L.; Lux, S.E.; Mohandas, N. 1998: Deficiencies in membrane proteins of the RBC affect the shear rigidity of cells but not the deformability of the membrane-skeletal network. Biophysical Journal 74(2 Part 2): A393

Sasich, L.D.; Wolfe, S.M. 1997: Deficiencies in patient information leaflets concerning gastrointestinal complications of nonsteroidal anti-inflammatory drugs. Jgim 12(Suppl 1): 79

LuZuoMei 2008: Deficiencies in previous studies on early generation stability of rice and its corresponding suggestions. Chinese Journal Of Rice Science: 3, 321-322

Nakhleh, R.E.; Zarbo, R.J. 1996: Deficiencies in surgical pathology specimen identification and accessioning A CAP Q-probes study of 1,004,115 cases from 417 institutions. Modern Pathology 9(1): 166A

Sickles, E.A.; Kopans, D.B. 1993: Deficiencies in the analysis of breast cancer screening data. Journal of the National Cancer Institute 85(20): 1621-1624

Marx, S.J.; Eil, C.; Liberman, U.A.; Bliziotes, M.M.; Nanes, M.S.; Barsony, J.; Brandi, M.L. 1990: Deficiencies in the effector system for 1 25 dihydroxyvitamin d. Castells, S And L Finberg (Ed ) Clinical Pediatrics (New York), Vol 6 Metabolic Bone Disease in Children Xvii+386p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 171-188

Anonymous 1993: Deficiencies in trace metals especially copper and zinc observed during intravenous alimentation. Journal of the Japan Pharmaceutical Association 45(4): 444-445

Sweder, K.; Hanawalt, P.C. 1993: Deficiencies of DNA repair in yeast SSL2 strains. Environmental and Molecular Mutagenesis 21(Suppl 22): 68

Kazatchkine, M.D.; Fearon, D.T. 1990: Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21). Immunodeficiency Reviews 2(1): 17-41

Schwarz, K.B.; Cox, J.M.; Sharma, S.A.; Clements, L.; Humphrey, J.R.; Witter, F.A. 1992: Deficiencies of multiple antioxidant nutrients in inner city pregnant women despite alleged intake of prenatal vitamins. Pediatric Research 31(4 Part 2): 294A

Cohen, H.; Atoyebi, W.; Pickering, W.; Regan, L. 1997: Deficiencies of naturally occurring anticoagulants in women with recurrent miscarriage. British Journal of Haematology 97(Suppl 1): 81

Seliger, B.; Hoehne, A.; Jung, D.; Knuth, A.; Schrier, P.; Tampe, R.; Momburg, F.; Huber, C. 1995: Deficiencies of the MHC class I antigen presentation machinery of renal cell carcinoma cells and their restoration by gene transfer. Onkologie 18(Suppl 2): 33

Croy, B.A.; Guimond, M.J. 1995: Deficiencies reproduction performance of the NK cell-depleted tg-epsilon-26 mouse. Natural Immunity 14(2): 79-80

Fernie, B.A.; Hobart, M.J. 1998: Deficiency Seven further molecular defects and their associated marker haplotyes, including five new polymorphisms. Molecular Immunology 35(6-7): 341

Wundrack, I.; Kehrer, H.; Janka, M.; Dobosz, T.; Blin, N. 1995: Deficiency alleles of the detoxification gene CYP2D6 appear to be associated with neurofibromatosis type 2. International Journal of Oncology 7(Suppl ): 953

Birchler, J.A. 1994: Deficiency analysis. Freeling, M, Walbot, V The maize handbook 494-495

Mathieson, P.W.; Peters, D.K. 1993: Deficiency and depletion of complement in the pathogenesis of nephritis and vasculitis. Kidney International. Supplement 42: S13-S18

Yang, M.; Sun, J.; Zhang, T.; Liu, J.; Zhang, J.; Shi, M.A.; Darakhshan, F.; Guerre-Millo, M.èl.; Clement, K.; Gelb, B.D.; Dolgnov, G.; Shi, G.-P. 2008: Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice. Arteriosclerosis Thrombosis and Vascular Biology 28(12): 2202-2208

Straniero, S.; Cavallini, G.; Donati, A.; Metelli, M.Rita.; Tamburini, I.; Pietrini, P.; Bergamini, E. 2008: Deficiency and supplementation of PUFA in the diet have similar effects on the age-associated changes in rat-plasma cholesterol levels. Mechanisms of Ageing and Development 129(12): 759-762

So, Y.en, T.; Simon, Roger, P. 1996: Deficiency diseases of the nervous system. Bradley, W G, Daroff, R B, Fenichel, G M, Marsden, C D Neurology in clinical practice, Second edition, Vols 1 and 2 Principles of diagnosis and management, Vol 1 The neurological disorders, Vol 2 1373-1388

Gemayel, G.; Pautard, B.; Pautard, J.C.; Boudailliez, B.; Weiss, L.; Piussan, C. 1998: Deficiency in C3 fraction of complement and serious infections. Archives de Pediatrie 5(Suppl 2): 240S

Zhang, X.; Newman, E. 2008: Deficiency in l-serine deaminase results in abnormal growth and cell division of Escherichia coli K-12. Molecular Microbiology 69(4): 870-881

Van Gossum, A.; Closset, P.; Noel, E.; Neve, J.; Cremer, M. 1995: Deficiency in antioxidant factors in patients with alcohol-related chronic pancreatitis. Gastroenterology 108(4 Suppl): A397

H.Z.; Wells, P.G. 1990: Deficiency in bilirubin udp glucuronyltransferase as a genetic determinant of benzo a pyrene covalent binding in vitro. FASEB Journal 4(3): A609

Pozdnykova, O.O.; Prodeus, A.P.; Goerg, S.; Zhou, X.; Carroll, M.C. 1998: Deficiency in complement C4 or receptors CD21/CD35 leads to increased anti-nuclear and -dsDNA antibodies and disease in lpr mice. Molecular Immunology 35(6-7): 338

Burgeois, M.; Goutieres, F.; Chretien, D.; Rustin, P.; Munnich, A.; Aicardi, J. 1992: Deficiency in complex Ii of the respiratory chain, presenting as a leukodystrophy in two sisters with Leigh syndrome. Brain and Development 14(6): 404-408

Fanti, P.; Yan, F.X.; Wedlund, P.J. 1998: Deficiency in cytochrome P450-2D6 is associated with extreme levels of parathyroid hormone in renal failure patients. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 564A

Qian, S.; Mumick, S.; Nizner, P.; Tota, M.R.; Menetski, J.; Reitman, M.L.; Macneil, D.J. 2008: Deficiency in cytosolic malic enzyme does not increase acetaminophen-induced hepato-toxicity. Basic and Clinical Pharmacology and Toxicology 103(1): 36-42

Aoyama, A.; Scheier, B.; Frohli, E.; Stark, G.; Schaefer, R.; Klemenz, R. 1992: Deficiency in dexamethasone mediated accumulation of beta beta crystallin and concomitant acquisition of thermotolerance is a ras transformation specific phenotype in mouse nih 3t3 fibroblasts. Experientia 48(ABSTR): A68

Holroyd, K.J.; Crystal, R.G. 1991: Deficiency in host defense. Crystal, R G And J B West (Ed ) The Lung: Scientific Foundations, Vols 1 And 2 Xxxix+1207p (Vol 1); Xxxix+1016p (Vol 2) Raven Press: New York, New York, Usa Illus 1913-1924

Liao, D.; Malinow, R. 1996: Deficiency in induction but normal expression of LTP in hippocampal slices from young rats. Society for Neuroscience Abstracts 22(1-3): 1459

Müller Smith, K.; Fagel, D.M.; Stevens, H.E.; Rabenstein, R.L.; Maragnoli, M.E.; Ohkubo, Y.; Picciotto, M.R.; Schwartz, M.L.; Vaccarino, F.M. 2008: Deficiency in inhibitory cortical interneurons associates with hyperactivity in fibroblast growth factor receptor 1 mutant mice. Biological Psychiatry 63(10): 953-962

Markell, M.S.; Altura, B.T.; Sarn, Y.; Friedman, E.A.; Altura, B.M. 1993: Deficiency in ionized magnesium in long-term, stable renal transplant recipients. FASEB Journal 7(3-4): A509

Young, W.S.I.i; Shepard, E.; Amico, J.; Lamarca, M.E.; Mckinney, C.; Ginns, E.I. 1996: Deficiency in mouse oxytocin prevents lactation, but not fertility or parturition. Society for Neuroscience Abstracts 22(1-3): 1151

Nigro, M.A.; Johns, D.R.; Lee, C.P.; Tsang, S.; Rauchova, H.; Chang, C.H.; Paridon, S. 1991: Deficiency in nadh dehydrogenase and cytochrome b in a patient with a familial mitochondria myopathy. Neurology 41(3 Suppl 1): 178

Kugiyama, K.; Yasue, H.; Yoshito, I.; Okumura, K. 1996: Deficiency in nitric oxide bioactivity at spasm sites of epicardial coronary arteries in patients with coronary spastic angina. Journal of the American College of Cardiology 27(2 Suppl A): 130A

Goerg, S.; Chu, L.; Prodeus, A.; Zhou, X.; Shen, L.; Nezlin, R.; Carroll, M.C. 1997: Deficiency in the B cell coreceptor CD21/35 exacerbates autoimmune disease in lprlpr mice. Arthritis and Rheumatism 40(9 Suppl): S231

Rouvin, B.; Meudec, J.M. 1993: Deficiency in the Hageman factor, attitude and aptitude. Medecine et Armees 21(2): 153-154

Herrod, H.G.; Gross, S.; Valenski, W.R. 1991: Deficiency in the cd29 cd4 t helper inducer subpopulation of lymphocytes in children with recurrent infection. Journal of Allergy and Clinical Immunology 87(1 Part 2): 313

Montalto, J.; Warne, G.L.; Yong, A.B.W. 1997: Deficiency of 17-beta-hydroxysteroid dehydrogenase presenting before puberty In vivo and in vitro steroid studies. Hormone Research 48(Suppl 2): 111